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ABSTRACT 
Previous work by others has demonstrated that rat brain protein tyrosine 
phosphatase (rbPTP-1) exhibited increased reactivity toward substrates containing 
acidic residues N-temiinal to phosphotyrosine. We show that substrates containing 
a single acidic residue C-terminal to the phosphotyrosine also enhanced reactivity 
with rbPTP-1. A substrate aspartate residue at the P+2 position exhibited the 
greatest enhancement of reactivity. 
Surface basic residues of rbPTP-1 were investigated for their role in the 
increased reactivity due to substrate acidic residues. Mutation of R47 or K120 to 
alanine decreased the enhancement of reactivity due to acidic residues N-terminal 
to phosphotyrosine by 78% and 73% respectively compared to WT. These mutants 
also demonstrated decreased PTP reactivity with substrates containing a C-
terminal acidic residue by 69% and 52%, respectively. Mutation of both PTP 
residues almost completely abrogated the enhancement of reactivity due to 
substrate acidic residues, decreasing reactivity approximately 90%.. Mutation of 
R24 or K36 to alanine had a smaller effect on the enhancement of reactivity due to 
substrate acidic residues, decreasing enhancement of reactivity 40% for R24A, and 
48% for K36. In all cases, kinetic analysis showed that the changes in reactivity 
primarily affected the Km only. With substrates containing multiple acidic residues, 
WT and mutant PTP's both demonstrated additivity of the enhancment effect, but 
R47A and K120A mutants exhibited no difference in reactivity enhancement with 
substrates containing a single substrate acidic residue at position P-1 or P-5. 
These results suggest a general type of interaction between substrate acidic 
residues and PTP basic residues. 
To examine the effect of substrate acidic residues on substrate binding, a 
cysteine-to-serine mutant of rbPTP-1 was used. This mutation inactivated the 
enzyme, but preserved substrate binding ability. Peptide substrates demonstrated 
much higher affinity for PTP binding than para-nitrophenyi phosphate, a 
phosphotyrosine analog. Peptides containing single acidic residues at P-1, P-2, P-
5, or P+2 all showed increased binding affinity for rbPTP-1 versus peptides without 
acidic residues. The effect of the number of substrate acidic residues on binding 
was additive. These results indicate that the reactivity enhancement of rbPTP-1 
due to substrate acidic residues is a direct binding effect. 
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CHAPTER 1. GENERAL INTRODUCTION 
One of the most important signal transduction processes involved in cell 
regulation is reversible phosphorylation. This process entails the addition or removal 
of phosphate from amino acid residues in proteins, most commonly serine, 
threonine, and tyrosine. Phosphorylation was first discovered in the study of 
epinephrine-regulated glycogen metabolism (Krebs & Fischer, 1956). Tyrosine 
phosphorylation was first detected approximately 20 years later in the study of 
transforming viruses (Hunter & Sefton, 1980). Since these first discoveries, 
phosphorylation has been found to regulate or be involved in virtually every cellular 
signal transduction and regulatory pathway studied. 
Reversible phosphorylation is controlled by two functional groups of enzymes, 
protein kinases, which attach phosphate, and protein phosphatases, which remove 
phosphate. In general, these enzymes are active toward phosphotyrosine 
exclusively, or toward phosphoserine and/or phosphothreonine residues. A group of 
kinases (Dailey et al., 1990) and phosphatases (Guan et al., 1991) have recently 
been discovered that can add or remove phosphate from serine, threonine, and 
tyrosine. These enzymes are termed dual specificity enzymes. 
Analysis of gene sequences of serine/threonine and tyrosine kinases 
illustrated that these proteins belong to a single gene family (Hanks et al., 1988). 
Similar analysis of protein phosphatases, however, revealed that serine/threonine 
and tyrosine phosphatases encompass several separate gene families (Pot & Dixon, 
1992). This dissertation will focus on the protein tyrosine phosphatases. 
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The Protein Tyrosine Phosphatase Family 
The protein tyrosine phosphatase (PTP) family is a group of enzymes having 
a high degree of homology within a 250-amino acid stretch known as the PTP 
domain. Over 40 distinct PTP cDNA's have been identified, and all contain this PTP 
domain. In addition, PTP's are divided into three main groups based on other 
portions of the gene sequence. These groups are the transmembrane group, the 
cytoplasmic group, and the dual-specificity group. 
The transmembrane group structure consists of either one or two tandem 
PTP domains, a single transmembrane domain, and varied extracellular domains 
(Pot & Dixon, 1992; Krueger & Saito, 1992; Fischer et al., 1991). The 
transmembrane group of PTP's are further divided based on the structure of the 
extracellular domain. Type I PTP's contain a highly O- and N-glycosylated 
extracellular domain, as demonstrated by CD45 (Pulido & Sanchez-Madrid, 1992). 
Type II PTP extracellular domains have clusters of immunoglobulin-like domains and 
fibronectin type Hi (FN III) repeats, as shown in the PTP LAR (Streull et al., 1988). 
Other members of this class are HPTPk and HPTPji (Jiang et al., 1993; Gebbink et 
al., 1991). This domain organization shows striking homology to the adhesion 
molecule N-CAM (Streuli et al., 1988). Type III PTP's contain only FN III repeats in 
their extracellular domain, as shown in HPTPp, DPTP10D, and DPTP99A (Yang et 
al., 1991; Hariharan et al., 1991; Tian et al., 1991). Type IV PTP's contain a very 
short extracellular domain, as shown by HPTPa and HPTPe (Kaplan et al., 1990; 
Krueger et al., 1990). Type V PTP's contain in their extracellular domain a region 
with homology to the enzyme carbonic anhydrase. PTP's in this class are HPTP  ^
and RPTPy (Krueger & Saito, 1992; Bamea et al., 1993). 
The cytoplasmic PTP group consists of a single PTP domain and various 
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other sequences that have been postulated to serve either in regulation of PTP 
activity or in targeting the PTP to particular subcellular compartments. Protein 
sequences targeting the enzyme to the endoplasmic reticulum have been identified 
(Mauro et al., 1993; Frangioni et al., 1992; Woodford-Thomas et al., 1992). Putative 
targeting sequences for the nucleus (McLaughlin & Dixon, 1993; Flores et al., 1994, 
Tillmann et al., 1994), and the cytoskeleton (Gu et al., 1991; Yang & Tonks, 1991) 
have also been identified in PTP sequences. A sub-family of PTP's contain 
functional SH2 domains that are involved in targeting the PTP to tyrosine 
phosphorylated proteins, most often found in signalling complexes on surface 
receptors (Feng & Pawson, 1994). PTP-PEST contains sequences that have been 
found in other proteins that undergo rapid degradation (Yang et al., 1993). 
The dual-specificity PTP's are characterized by VH1 (Guan et al.,1991), 
cdc25 (Dunphy & Kumagai, 1992; Gautier et al., 1992), and map kinase 
phosphatase (mkpase) (Keyse and Emslie, 1992; Charles et al., 1993; Rohan et al., 
1993; Doi et al., 1994). These proteins are distinguished from the other PTP classes 
by their ability to dephosphorylate phosphoserine, -threonine, and -tyrosine in vitro 
and in vivo. The gene sequences, however, show only limited homology to the other 
PTP's, except in a small region of the PTP domain called the HC box, which will be 
described later. 
PTP-1B is the prototype for PTP family. It was the first enzyme to be purified 
to homogeneity (Tonks et al., 1988a) and one of the first PTP's to be characterized 
biochemically (Tonks et al., 1988b). The amino acid sequencing conducted on this 
enzyme (Charbonneau et al., 1989) enabled the identification of CD45 as a PTP, 
and the identification of the PTP's as a gene family. PTP-1 B was also one of the first 
enzymes where a phosphoenzyme intermediate was demonstrated (Guan & Dixon, 
1991). Extensive substrate characterization has been done with this enzyme 
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(Hippen et al,, 1993; Zhang et al., 1993, 1994a). This enzyme was also one of the 
first to be crystallized, giving a picture of the 3-D structure. (Barford et al., 1994). 
Because so much is known about this enzyme, it is an ideal candidate in which to 
study substrate reactivity and binding. 
The functional role of PTP-1B in vivo has yet to be identified. PTP-1B has 
been cloned from human placenta (Brown-Shimer et al., 1990; Chemoff et al., 1990) 
and rat brain (Guan et al., 1990); the enzymes show 97% identity with each other 
within the FTP domain. This enzyme is ubiquitously expressed (Chemoff et al., 
1990). PTP-1 B is targeted to the cytoplasmic face of the endoplasmic reticulum by a 
C-temiinal sequence (Frangioni et al., 1992; Woodford-Thomas et al., 1992; Mauro 
et al., 1992), and its activity may be regulated by proteolytic cleavage of this 
sequence (Frangioni et al., 1993). Growth factor-inducible altemative splicing of 
PTP-1 B has been detected, resulting in an altered C-terminus (Shifrin & Neel, 1993). 
Interestingly, the C-temiinal sequence of the alternatively-spliced product is identical 
to the rat brain isoform. The significance of this is unknown. PTP-1 B may also be 
regulated by differential cell cycle-dependent serine/threonine phosphorylation 
(Schievella et al., 1993; Flint et al., 1993). This enzyme is implicated in, among 
others, platelet activation (Frangioni et al., 1993) and in the downregulation of the 
insulin receptor kinase (Goldstein, 1993). 
Biological Roles of PTP's 
The roles of PTP's in cellular regulation have been difficult to study, mainly 
due to the lack of knowledge about physiologically relevant substrates. Despite this 
technical problem, however, PTP's have been shown to play important roles in many 
signaling pathways. 
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Lymphocyte activation. The first PTP demonstrated to be critical for cell 
regulation was CD45. This protein is expressed exclusively in cells of hematopoietic 
origin. The importance of this protein in T-cell signaling was demonstrated in CD45-
cells, where absence of the protein resulted in abrogation of the downstream signals, 
including Ca2+ influx, PIP2 hydrolysis, and IL2 gene expression (Pingel & Thomas, 
1989). CD45 also has a critical role in B-cell activation (Justement et al.., 1991) and 
in neutrophils (Chi et al., 1994). An active cytoplasmic domain, but not the 
extracellular domain, is required for this effect in T-cells (Trowbridge & Thomas, 
1994; Desai et al., 1994). In addition, localization of the PTP to the plasma 
membrane, either by a transmembrane segment, or a covalent lipid, is required for 
T-cell activation (Desai et al., 1993; Hovis et al., 1993; Volarevic et al., 1993). 
Dephosphorylation of src family kinases, and their subsequent activation, is 
required for T-cell activation (McFarland et a!., 1993; Lee et al., 1994). It is 
postulated that CD45 dephosphorylates pse'^ "  ^and pSg'v", src family kinases, whose 
dephosphorylation is required for activation of their kinase activity. CD45 can 
dephosphorylate both kinases in vitro (Ostergaard et al., 1989; Mustelin et al., 1989; 
Mustelin et al., 1992), and the activity of both kinases is decreased in CD45- cells 
(Katagiri et al., 1995; Desai et al., 1994; Biffen et al., 1994; McFarland et al., 1993). 
CD45 also associates with p56'ck in activated T-cells (Gervais & Veillette, 1995; 
Autero et al., 1994) and with p53/56'y" in B-cells (Brown et al., 1994; Burg et al., 
1994). In addition, CD45 efficiently dephosphorylates both proteins and peptides 
corresponding to the fyn, Ick, and lyn inhibitory phosphorylation site in vitro (Cho et 
al., 1993; Hippen, 1993), which suggests that CD45 may indeed function to activate 
these kinases in vivo. 
Control of mitogenesis at the membrane. Much work has been done to 
elucidate the mechanism by which cells respond to their environment. Recent 
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evidence indicates that SH-PTP's, enzymes that contain tandem SH2 domains in 
addition to their catalytic PTP domain, may be involved in some of the early signaling 
events. SH-PTP1 (also known as HCP, SHP, and PTP1C) is one group of SH-PTP's 
(Shen et al., 1991; Plutzky et al., 1992; Yi et al., 1992; Matthews et al., 1992); it is 
expressed primarily in cells of hematopoietic origin, but is also expressed in 
epithelial cells. The other group is SH-PTP2 (also known as syp, PTP1D, PTP2C, 
and SH-PTP3) (Freeman et al., 1992; Feng et al., 1993; Vogel et al., 1993; Adachi et 
al., 1992; Ahmad et al., 1993). In contrast to SH-PTP1, this group more widely 
expressed in embryonic and adult tissues. This family of enzymes have been 
implicated in various regulatory pathways, either as positive or negative regulators of 
signal transduction. 
Positive regulation: SH-PTP2. SH-PTP2 has been identified as a critical 
component of the early mitogenesis signal cascade for a variety of growth factors, 
including the platelet-derived growth factor (PDGF), epidermal growth factor (EGF) 
and insulin. A similar series of events is common to the binding of these peptides to 
their respective receptor, all of which are protein tyrosine kinases. Binding of the 
appropriate factor activates the kinase domain, and results in the 
autophosphorylation of the receptor, and binding of proteins to the phosphorylated 
regions via SH2 domains; many of these proteins are also phosphorylated by the 
receptor. One of the proteins often found complexed with activated receptors is 
Grb2. This protein contains only SH2 and SH3 domains. It associates with mSos, a 
GDP-GTP exchange factor, via the GrtD2 SH3 domains. Recruitment of the Grb2-
mSos complex to the membrane results in the activation of p21 raf protein kinase, 
and the map kinase cascade; the final result is the activation of gene transcription 
(van der Geer et al., 1994; Schlessinger, 1994) 
SH-PTP2 specifically binds to the PDGF receptor (Kazlauskas et al., 1993; 
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Bennett et al., 1994), the EGF receptor (Tomic et al., 1995), the insulin receptor 
(IRK) (Staubs et al., 1994; Maegawa et al., 1994; Maegawa et al., 1993), and insulin 
receptor substrate-1 (IRS-1) (Kuhneetal., 1993; Hausdorff etal., 1995; Yamauchi et 
al., 1995; Lechleider et al., 1993), a protein involved in early insulin signalling. SH-
PTP2 is phosphorylated at tyrosine 528 by the PDGF receptor and IRK (Bennett et 
al., 1994, Stein-Gerlach et al., 1995; Maegawa et al., 1994); this site efficiently binds 
Grb2 in vivo (Bennett et al., 1994, Stein-Gerlach et al., 1995). In the case of the 
PDGF receptor, Grb2 associates with the receptor only via its interaction with 
phosphorylated SH-PTP2. A similar pathway has been identified genetically in 
Drosophila: epistasis studies demonstrated that corkscrew, a relative of SH-PTP2, 
is involved genetically after torso (a receptor tyrosine kinase), and in concert with raf, 
(Perkins et al., 1992), a serine/threonine kinase shown in mammalian systems to be 
involved in the map kinase cascade. Homologs of Grb2 and mSos have been 
identified, and it is conceivable that corkscrew acAs similarly in Drosophila. SH-PTP2 
also promotes the association of IRS-1 with IRK (Kharitonenkov et a!., 1995) by 
serving a similar adaptor function. Preventing these interactions by microinjection of 
SH-PTP2 SH-2 domains or antibodies to SH-PTP2 can block map kinase activation 
(Milarski & Saltiel, 1994) and DNA synthesis (Xiao et al., 1994; Hausdorff et al., 
1995). In cultured adipocytes, microinjection of SH-PTP2 SH2 domains also 
inhibited the ras-dependent increased transcription of the gene for the glucose 
transporter GLUT1, while not affecting translocation of another glucose transporter, 
GLUT4, to the cell surface (Hausdorff et al., 1995), which is a ras-independent 
process. These studies indicate an important role for SH-PTP2 as an adaptor 
protein in signalling complexes. 
The phosphatase activity of SH-PTP2 is also important in early growth factor 
signalling. In vitro engagement of the SH2 domains by peptides from PDGF 
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receptor or IRS-1 or deletion of the SH2 domains increases the PTP activity of SH-
PTP2 (Townley et al., 1993; Huyer et al., 1995). Microinjection or expression of a 
catalytically inactive mutant of SH-PTP2 also inhibits p21'^  activation, map kinase 
activation (Noguchi et al., 1994; Zhao et al., 1995), and c-fos induced transcription 
(Yamauchi et al., 1995), suggesting that dephosphorylation of proteins may be 
important in propagating the signal from the receptor. 
As yet, downstream potential substrates of SH-PTP2 have not been identified. 
However, SH-PTP2 has been shown to dephosphorylate the phosphatidylinositol-3-
kinase and GTPase activating protein binding sites of the PDGF receptor 
(Klinghoffer & Kazlauskas, 1995) and IRS-1 (Kuhne et al., 1994); both proteins are 
phosphorylated after association with an activated receptor kinase. That SH-PTP2 
can dephosphorylate these proteins suggests a potetial negative role in mitogenesis 
for this PTP as well. 
Negative regulation: SH-PTP1. In contrast to the positive role of SH-PTP2 in 
early signal transduction events, SH-PTP1 appears to have a negative role. A 
potential function for SH-PTP1 was first suspected by the analysis of two 
spontaneous autosomal mutations in the mouse that cause a "scruffy" coat 
appearance (Shultz et al., 1993; Tsui et al., 1993). These mutations, termed 
motheaten (me),and viable motheaten {me  ^ in mice cause gross abnormalities in 
hematopoiesis, including increased numbers of erythrocyte progenitors, 
macrophages, and granulocytes, and T-ceils and natural killer cells with defective 
activity; affected animals developed systemic autoimmune disease and died within 1 
or 3 months, respectively. Gene analysis demonstrated that the me mutation results 
in truncation of the protein within the first SH2 domain, and an absence of PTP 
activity. The me  ^mutation results in either a small deletion or insertion within the 
PTP domain; the SH2 domains are functional, but the protein has approximately 10-
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fold less PTP activity (Tsui et al., 1993; Shultz et al., 1993; Kozlowski et al., 1993). 
That mutations in SH-PTP1 result in increased numbers of various 
hematopoietic cells suggested that SH-PTP1 may negatively regulate the mitogenic 
response of these cells to cytokines. This effect has been demonstrated in cells of 
the erythroid or macrophage lineage. In these cells, cytokine receptors associate 
with separate kinases, members of the Janus kinase family (Jak). Receptor binding 
results in the activation of the Jak kinases and phosphorylation of the receptor. 
Activation of these kinases results in activation of the stat transcription factors and in 
gene transcription (Ihle et al., 1995). 
SH-PTP1 associates with some cytokine receptors after phosphorylation. 
This has been demonstrated for the erythropoietin receptor (EpoR) (Klingmuller et 
a!., 1995; Yi et al., 1995; Tauchi et al., 1995), the interferon a receptor (IFNaR) 
(David et al., 1995; Yetter et al., 1995), and the interleukin 3 receptor p-chain (Yi et 
al., 1993). In these cases, when SH-PTP1 is prevented from binding to the 
phosphorylated receptor (Klingmuller et al., 1995), or in cells from me animals (David 
et al., 1995), Jak2 and Stati specifically demonstrate increased prolonged 
phosphorylation. Also, tyk2, a Jak family member that associates with IFNaR, was 
dephosphorylated by SH-PTP1 in vitro, suggesting that this kinase may be an in vivo 
substrate (Yetter et al., 1995). 
SH-PTP1 also has a negative regulatory role in B-cells. SH-PTP1 can 
associate with CD22 and FcyRIIBI, surface proteins that are phosphorylated after 
activation of B-cells by cross-linking with the B-cell receptor (Doody et al., 1995; 
D'Ambrosio et al., 1995). In the case of the FcyRIIBI-SH-PTP1 interaction, binding 
via the PTP's SH2 domains results in increased PTP activity, and mutation of the 
binding site in the receptor causes hypersensitivity of B-cells to antigen stimulation 
(D'Ambrosio et al., 1995). A similar hypersensitivity was observed in B-cells isolated 
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from me mice (D'Ambrosio et al., 1995) and wlien tine CD22-SH-PTP1 complex was 
prevented from co-ligating with the B-cell receptor complex (Doody et al., 1995), 
indicating that SH-PTP1 may serve as a "brake" on B-cell activation. 
Control of mitogenesis-downstream signaling. In a cell, many proteins 
are phosphorylated after treatment with various growth factors. One phosphatase, 
the dual specificity PTP map kinase phosphatase (mkpase), has been shown to be 
involved in dephosphorylaing key enzymes that are activated by phosphorylation 
during mitogenesis. This enzyme family demonstrates increased mRNA expression 
when cells are exposed to environmental stress, or when cells are stimulated with 
growth factors (Keyse and Emslie, 1992; Charles et al., 1992; Rohan et al., 1993). 
In these cases, map kinase family members are activated by phosphorylation on 
serine and tyrosine. Mkpase has been shown to dephosphorylate map kinase in 
vitro, and its protein expression correlated temporally with the time course of map 
kinase dephosphorylation and with the decrease in map kinase activity (Sun et al., 
1993), suggesting that this PTP is involved in shutting down the mitogenesis signal 
at the nucleus. Also, overexpression of mkpase decreases mRNA and DNA 
synthesis usually associated with map kinase activation (Brondello et al., 1995). 
However, in PC12 cells, treatment with actinomycin D and cycloheximide (preventing 
mkpase transcription and translation) did not affect the transient activation of map 
kinase (Wu et al., 1994), suggesting that, in some cases, other phosphatases may 
also inactivate map kinase in vivo. 
Mkpase can also dephosphorylate relatives of the map kinases, the c-jun N-
terminal kinases or stress-activated protein kinases (Y. Liu et al., 1995). These 
kinases are activated during cell stress, including exposure to ionizing radiation, 
cyanide, tunicamycin, cycloheximide, heat shock, tumor necrosis factor a and 
interleukin Ip (Kyriakis et al., 1994; Derijard et al., 1994; Pombo et al., 1994) and 
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specifically phosphorylate and activate c-jun (Adier et al., 1992; Hibi et al., 1993) and 
other transcription factors (Abdel-Hafiz et al., 1992). This results in the increase in 
transcription of genes involved in environmental stress control. Mkpases may play a 
role in the down-regulation of these pathways in a similar manner to its role in the 
down-regulation of map kinase and the mitogenic signal (Y. Liu et al., 1995). 
Cell cycle regulation. PTP's are required for proper regulation of cell cycle 
progression. The cell cycle of all eukaryotes is controlled in part by a protein duplex 
called maturation promoting factor (MPF), that consists of a serine/threonine kinase, 
p34cdc2  ^ and a regulatory protein, cyclin (Nurse, 1990; Lewin, 1990). The kinase 
activity of MPF is controlled by its phosphorylation state. Early studies in yeast 
demonstrated that mutations in the cdc25 gene resulted in a block at mitosis in these 
cells (Gould & Nurse, 1989), which could be reversed by expression of the T-cell 
phosphatase (Gould et al., 1990). Further studies demonstrated that the protein 
product p80cdc25 vvas the PTP responsible for dephosphorylating and activating 
MPF, both in vitro and in vivo (Strausfeld et al., 1991; Dunphy & Kumagai, 1991; 
Gautier et al., 1991; Millar et al., 1991). 
It is unclear at present exactly what triggers the dephosphorylation of MPF by 
cdc25 at the G2/M transition. Much evidence in mammalian systems demonstrated 
that the human cdc25C gene product is phosphorylated on serine during mitosis, 
and that this phosphorylation increases PTP activity toward either pNPP or the 
p34ccic2 tyrosine 15 phosphorylation site (Hoffmann et a!., 1993; Strausfeld et al., 
1994). This cdc25 phosphorylation event may be catalyzed by the p34cdc2/cyclin B 
complex directly (Hoffmann et al., 1993) or by an as yet unidentified kinase (Izumi & 
Mailer, 1995). Treatment of cycling extracts from Xenopus oocytes with microcystin, 
an inhibitor of the serine/threonine phosphatase 2A, prevents the phosphorylation of 
cdc25C (Clarke et al., 1993; Kumagai & Dunphy, 1992), suggesting that this 
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phosphatase may be be involved in regulating the timing of cdc25C phosphorylation 
and subsequent activation. In addition, two other cdc25 isoforms are present in 
mammalian cells at the G2/M transition; one of the isoforms, cdc25A, shows an 
increase in activity in vitro by interaction with cyclin B (Gaiaktionov & Beach, 1991). 
cdc25A may also serve as a trigger for cdc25C activation, and subsequent activation 
of MPF. 
The regulation of MPF phosphorylation also involves other PTP's. MPF 
phosphorylation is maintained by the balance of specific kinase and phosphatase 
activities in the cell. MPF is phosphorylated and inactivated by the dual specificity 
kinases wee1 and miki (Lundgren et al., 1991). In yeast, these kinases are further 
regulated by two PTP's with overlapping function, pyp1 and pyp2 (Ottilie et al., 1991; 
Millar et a!., 1991). In addition, a third PTP, pyp3, may act in concert with p80'=''^ 5 to 
dephosphorylate MPF (Millareta!., 1992). 
Pathogenesis. Until recently, PTP's had been identified only in eukaryotes. 
Therefore, it was a surprising discovery that PTP's are virulence detemriinants in a 
group of viruses and a bacteria! genus. The first virulence determinant identified as 
a PTP was found in the bacteria Yersinia pseudotuberculosis, which causes a type 
of pneumonia. This bacteria is related to /. pestis, which caused the Black Plague 
in the middle ages. An open reading frame was discovered that codes for a 
functional PTP, termed YOP-51 (Guan & Dixon, 1990). Introduction of a catalytically 
inactive fonn of YOP-51 into the bacteria resulted in a loss of viailence (Bliska et al., 
1991; Bolin & Wolf-Watz, 1988). During an infection with Yersinia, macrophages 
phagocytose the bacteria. YOP-51 specifically dephosphorylates macrophage 
proteins in vivo after phagocytosis (Bliska et al., 1991). This dephosphorylation 
correlates with impaired Fc receptor-mediated signalling in infected macrophages, 
resulting in a reduced oxidative burst response (Bliska & Black, 1995). 
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A dual specificity PTP, VH1, was discovered as an open reading frame in 
vaccinia virus, exhibiting limited homology within the HC-box region of the PTP 
domain (to be described later) (Guan et al., 1991). This PTP is packaged within the 
virus particle during replication, and is required for virus replication; without VH1, 
virus particles are produced that are not infectious (K. Liu et al., 1995). VH1 
dephosphorylates viral proteins in vivo; it is proposed to dephosphorylate, among 
other candidates, the viral protein F18, which is required for viral replication (K. Liu et 
al., 1995). The myxoma virus and shope virus, members of the vaccinia family 
(Mossman et al., 1995), and viaises in the orthopox and baculovirus groups (Hakes 
et al., 1993) also contain a PTP coding region homologous to VH1 in the vaccinia 
virus, suggesting that VH1 's function in vaccinia virulence is a common strategy of 
viral virulence in these groups. 
The PTP Catalytic Mechanism 
Comparison of primary sequences demonstrates that PTP's share the 
greatest degree of homology in an approximately 200 amino acid region, the PTP 
consensus domain. All PTP's in the transmembrane and cytoplasmic PTP classes 
so far identified contain a highly conserved region known as the HC-box. The HC-
box is an eleven amino acid sequence with the consensus sequence 
[IA^HCXAGXXR[S/T] (Pot and Dixon, 1992), where X is any amino acid. The dual-
specificity PTP's exhibit less homology in this region, but do share the cysteine and 
arginine. This region of the enzyme is the active site, as discussed below. 
There are three main events that occur during catalysis, as proposed by 
Zhang et al. (1994b) and diagrammed In Figure 1.1. A phosphorylated substrate first 
binds to the enzyme active site. Next, phosphate is transferred to the catalytic 
cysteine, forming a phosphoenzyme intermediate. The last step is the hydrolysis of 
Figure 1.1. Diagram of the proposed PTP catalytic mechanism. Drawing is based 
on a model proposed by Zhang, etal, 1994b. 
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the phosphoenzyme intermediate. The evidence for each of these steps is 
summarized below. 
Substrate binding. Binding of the substrate to the active site requires 
coordination of at least two components, the phosphate, and the tyrosine side chain. 
Early evidence suggested that an arginine residue may be involved in coordinating 
the phosphate during binding and catalysis. Treatment of rat brain PTP-1 with the 
arginine-modifying reagent phenylglyoxal inactivated the enzyme; the enzyme could 
be protected with substrate, supporting the presence of an essential arginine in the 
active site (Hippen, 1993). An arginine residue is conserved in the HC-box of all 
PTP's. Mutation of this arginine residue in LAR (Streuli et al., 1989,1990) and CD45 
(Johnson et al., 1992) also abolishes enzyme activity, suggesting an essential 
function. Kinetic analysis of this arginine mutation in YOP-51 demonstrated that 
mutation of this arginine (R409) to alanine drastically decreased the kcat (Zhang et 
al. 1994c), indicating that this arginine most likely is involved in catalysis. 
Structural studies have confimned this previous work. In co-crystals of PTP-
1B and tungstate, a phosphate analog and PTP inhibitor, R221 coordinates two of 
the oxygens of the bound tungstate (Barford et al., 1994). In the YOP-51 rtungstate 
structure, the bound tungstate is coordinated both by the guanidinium group of R409 
(analogous to R221 above) and by the main chain nitrogen atoms of amino acids 
404-408 (Stuckey et al., 1994). 
The interaction between the substrate tyrosine and PTP residues have also 
been observed in PTP-1 Brphosphopeptide and PTP-1 Brphosphotyrosine co-crystals. 
In both cases, the phenyl ring of the substrate tyrosine is coordinated by a series of 
hydrophobic interactions with the side chains of F182, A217,1219, Y46, and V49 (Jia 
et al., 1995). A similar hydrophobic pocket is observed in YOP-51 rtungstate crystals 
(Stuckey et al., 1994). The an-angement of hydrophobic residues in the PTP active 
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site is much different than the basic residue-tyrosine ring arrangement in SH2 
domain binding to phosphotyrosine-containing peptides (Waksman et al., 1993), 
suggesting multiple methods for binding phosphotyrosyl residues. 
Phosphoenzyme intermediate formation. All PTP's thus far examined 
have within the HC-box a conserved cysteine residue. The cysteine has been 
shown to be essential for activity. Mutation of this residue in all PTP's thus far 
examined, and chemical modification of this residue in LAR with a variety of thiol-
modifying groups (Pot et al,, 1991), completely abolishes activity. Examination of 
the ionization state of this cysteine indicates a pKa of 4.8; this is much lower than the 
expected pKa of 8.5 (Lundbladt & Noyes, 1984), and suggests that the thiolate anion 
must be stabilized in the active site by surrounding residues (Zhang & Dixon, 1993). 
Structural analysis of PTP-1B and YOP-51 suggest that in the free enzyme, the 
charge of the cysteine is stabilized by hydrogen bonds to main-chain nitrogen atoms 
(residues 216-220 in PTP-1B; residues 404-410 in YOP-51) (Barford et al., 1994; 
Stuckey et al., 1994). 
Rat brain PTP-1 and LAR have demonstrated the formation of a 
phosphoenzyme intemiediate during catalysis by phosphoenzyme trapping (Guan & 
Dixon, 1991; Pot et al., 1991). The intermediate contains a thiophosphate linkage, 
demonstrated by chemical characterization (Guan & Dixon, 1991) and S'lp NMR 
analysis (Cho et al., 1992). A phosphoenzyme intennediate is also fornied by VHR, 
the human homolog of the dual specificity PTP VH1 (Denu et al., 1995a). VHR 
requires the active site cysteine for dephosphorylation of both tyrosine and 
threonine; this evidence indicates a central role for the conserved cysteine residue in 
the catalytic mechanism (Denu et al., 1995a). The rate of phosphotyrosine-
containing peptides, however, was approximately 300-fold faster than the rate of 
phosphothreonine peptide dephosphorylation. 
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The positioning of the reactive cysteine for nucleophiiic attack of the substrate 
phosphate is most likely mediated by a GXgRXg sequence, where only the first 
glycine is conserved, and the other two positions are glycines in the majority of 
tyrosine-specific PTP's. Dual specificity PTP's exhibit much less homology of 
glycines in this region, and the implications for this in dual specificity PTP structure 
are unknown. Many PTP's contain this characteristic nucleotide binding fold 
sequence also present in dehydrogenases and kinases (Buehner et al., 1973; Hanks 
et al., 1988). In both PTP structures, the GXgRXg sequence forms a loop that 
positions the reactive cysteine opposite of the active site arginine, in optimal position 
for nucleophiiic attack by cysteine of the substrate phosphate (Barford et al., 1994; 
Stuckey et al., 1994). This loop also positions the main chain nitrogens in postions 
to forni the network of hydrogen bonds that neutralizes the thiolate charge. 
Phosphate transfer mechanism. Transfer of the phosphate first to the 
enzyme cysteine and then to water is proposed to occur via a general acid/base 
reaction (see Rgure 1.1); in YOP-51, the putative residues involved are D356 and 
E290. These two residues are conserved in all PTP's examined to date. When 
mutated to asparagine and glutamine respectively, the pH dependence of the kcat 
disappears on the basic and acidic limb of the curve respectively, suggesting that 
both residues are involved in an acid/base reaction (Zhang et al., 1994d). The 
relative position of the proposed general acid has been observed in crystal 
structures of PTP-1B, strongly suggesting the involvement of the aspartate in 
catalysis. In the PTP-1 Bitungstate structure, D181 (analogous to D356 in YOP-51) 
is oriented away from the active site (Barford et al., 1994). However, binding of a 
phosphopeptide substrate results in a confonnational change in the loop containing 
D181, bringing it into the active site and positioning it in an optimal confomiation to 
act as a catalyst (Jia et al., 1995). In addition, residue D92 in the dual specificity 
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PTP VHR is proposed to act as a general acid in catalysis, suggesting that while 
exhibiting limited homology to the tyrosine-spec'rfic PTP's, dual specificity PTP's use 
a similar catalytic mechanism (Denu et al., 1995b). 
The low molecular weight PTP's: part of the family, or unrelated? The 
low molecular weight PTP (LMWPTP) is one of a group of enzymes initially identified 
as acid phosphatases, and purified from a variety of tissues (Wo et al., 1992). 
Comparison of cDNA sequences between the LMWPTP and canonical PTP 
members demonstrate little sequence homology. Interestingly, these enzyme 
demonstrates some remarkable similarities to PTP kinetics and structure. 
Structurally, LMWPTP has a similar protein fold to PTP's and it contains the 
consented cysteine and arginine found in the PTP active site (M. Zhang et al., 1994; 
Logan et al., 1994). Kinetically, the reaction catalyzed by LMWPTP also proceeds 
via a phospho-cysteine intemnediate and the leaving group affects catalysis similar to 
PTP's (see below) (Davis et al., 1994). 
LMWPTP's thus far have an unknown function in cells. With their striking 
similarities with PTP's in terms of structure and catalytic mechanism, one must 
wonder if these enzymes also share substrate specificity. Initial analysis of purified 
enzymes indicate that, like PTP's, the LMWPTP's can dephosphorylate both aryl 
phosphates like pNPP and phosphotyrosyl peptides (Stefani et al., 1993) and 
proteins (Ramponi et al., 1989; Chemoff & Li, 1985). The kinetic parameters, when 
measured, show Km's in the high micromolar range, similar to YOP-51 and many 
receptor-type PTP's. Catalytic efficiency (kcat/Km), however, is approximately 2-3 
orders of magnitude lower than most members of the PTP family (Pinna & Donella-
Deana, 1994), calling into question whether these enzymes have an important 
regulatory function in vivo. Further studies are required to determine the 
relationship, if any, of the LMWPTP's to the PTP's. 
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Substrate Specificity of PTP's 
Of the many PTP's examined enzymaticaily, most of them exhibit very broad 
substrate reactivity. It is unclear why these enzymes can dephosphorylate such a 
wide variety of substrates in vitro; it is thought that in vivo systems must exist that 
restrict PTP access to substrates temporally or spatially, or that modify their activity 
by phosphorylation or association with other proteins. In addition, PTP's may be 
able to differentiate between potential substrates in a cell by specific binding or by 
recognition of sequences within the potential substrate. This avenue of investigation 
has suggested a potential mechanism of substrate specificity for PTP's. 
Studies using model substrates. Despite the lack of knowledge about in 
vivo PTP substrates, some information about substrate specificity has been gained 
by using model substrates. These substrates include proteins known to be 
phosphorylated in vivo, peptides based on known in vivo phosphorylation sites and 
model proteins phosphorylated in vitro. These model proteins include reduced, 
carboxymethylated and maleylated lysozyme (RCML) (Tonks et al., 1988a), myelin 
basic protein, and casein. Using the model substrates RCML and casein, rat brain 
PTP-1 dephosphorylated peptides corresponding to phosphorylation sites with 
kinetics similar to the intact protein, demonstrating that most of the substrate 
specificity detemninants are located adjacent to the phosphotyrosine. Peptides are 
also better substrates than aryl phosphates; the Km for a peptide substrate was 3-4 
orders of magnitude better than phosphotyrosine. In addition, substitution of 
naturally-occuring acidic residues in a RCML or casein peptide with alanine 
increased the Km of the peptide with rbPTP-1 3-4-fold; there was no effect on the 
Vm (Hippen et al., 1993). Similar results have also been observed with a peptide 
from the EGF receptor phosphorylation site (Zhang et al., 1994a) The charge of the 
acidic residue is also required; substitution of aspartate residues with asparagines 
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decreased the stimulation due to substrate acidics (Hippen et al., 1993). This effect 
of substrate acidic residues on reactivity has also been demonstrated with PTP-5 (a 
PTP purified to homogeneity from bovine brain (Jones et al., 1989)) (Hippen et al., 
1993), CD45, LAR (Hippen, 1993), the T-cell phosphatase (Ruzzene et al., 1993), 
HPTPp (Cho et al., 1993), and YOP-51 (Zhang et al., 1994a), with a variety of 
different peptide substrates. In some cases, substrate basic residues decrease 
substrate reactivity by increasing the Km (Ruzzene et al., 1993; Cho et al., 1993). 
These observations suggest that PTP's may have a general mechanism of 
interaction with the acidic residues found in many putative physiological substrates. 
Studies comparing rates of reactivity between PTP's for a substrate have also 
been done to examine if PTP's exhibit substrate selectivity. IRK contains a triply-
phosphorylated sequence whose phosphorylation at three tyrosines (Y1146, Y1150, 
and Y1151) (Zhang et al., 1991; Flores-Riveros etal., 1989; Tavare & Denton, 1988; 
Tomqvist et al., 1988; White et al., 1988) is required for the activation of kinase 
activity (Zhang et al., 1991; Flores-Riveros et al., 1989; White et al., 1988). 
Dephosphorylation of one residue in this region deactivates the kinase in vivo (King 
et al., 1991). In liver extracts, PTP activity specifically dephosphorylates IRK at 
positions 1150 and 1151 first, deactivating the kinase activity of the receptor (King & 
Sale, 1990). 
Using peptides derived from this site, it was found that the PTP's PTP-1B, 
CD45, LAR, and the T-cell phosphatase exhibit differences in the order of site 
dephosphorylation. PTP-1 B preferentially dephosphorylated residues 1150 and 
1151 faster than 1146; LAR and CD45 both dephosphorylated the sites in the 
preference order 1146 > 1151 > 1150. The T-cell phosphatase exhibited no 
preference in the sites (Ramachandran et al., 1993; Lee et al., 1992). However, 
LAR preferentially dephosphorylated site 1150 on an intact receptor; the rate of 
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dephosphorylation was two- to three-fold faster than for leukocyte antigen related 
protein (a CD45 homolog) and PTP-1B (Hashimoto et al., 1992). These studies 
indicate that some differences exist between the enzymes, and alludes to potential 
differences in substrate selectivity that may occur with IRK in vivo. 
PTP's exhibiting narrow substrate specificity. In contrast to tyrosine-
specific PTP's, narrow substrate specificity has been observed for the dual-
specificity PTP's. p80cdc25 specifically dephosphorylates the cdk family of protein 
kinases, and demonstrates very poor activity toward the model substrate RCML 
(Dunphy & Kumagai, 1991). A similar narrow substrate specificity is seen with the 
mkpase family, which dephosphorylates only map kinase and c-jun kinase family 
members with high specific activity (Sun et al., 1993; Y. Liu et al., 1995). 
Comparison of PTP substrate specificity with kinase specificity. In 
general, protein tyrosine kinases prefer substrates that contain acidics near the 
target tyrosine. This effect has been demonstrated for EGF receptor (Lee et al., 
1986), the PDGF receptor (Ronnestrand et al., 1990), and ppeo^-s  ^ (Tinker et a!., 
1992; Budde et al., 1995). Substrate acidic residues affect the Km of the kinase, 
and the magnitude of the effect of acidic substitution is on the order of 2-3-fold, 
similar to this effect with PTP's. However, the Km for peptide substrates is much 
higher for kinases than for PTP's (mM versus jiM for PTP's) (Geahlen & Harrison, 
1990), suggesting that kinases recognize secondary and tertiary structure of their 
substrates as well as primary sequence. 
Significance of This Work 
In this dissertation, I will discuss work that addresses the question of how 
PTP's recognize their substrates, from the perspective of PTP residues that are 
important in this process. Except in the crystal structure of PTP-1B and 
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phosphopeptide, no work has been done to address which PTP residues may be 
important in substrate reactivity. A mutagenesis approach to selectively mutate 
surface basic residues is described, along with a kinetic analysis of mutants with 
specific peptide substrates to determine the effect of the mutations on substrate 
reactivity and catalysis. Also, while kinetic data suggests that acidic residues affect 
interaction of the substrate with the PTP, any effects of substrate or PTP residues on 
binding have not been demonstrated. This work also examines the effect of both 
substrate and PTP residues on direct substrate binding. For these studies, a 
recombinant form of rat brain PTP-1 lacking the C-terminal hydrophobic domain was 
utilized. 
Dissertation Organization 
This dissertation is organized into two papers, which are in preparation for 
submission to the journal Biochemistry. The first paper discusses the effects of rat 
brain PTP-1 mutations on substrate reactivity due to acidic residues. The second 
paper discusses the role of substrate acidic and PTP basic residues on peptide 
binding. This is followed by a discussion of the relevance of these studies in 
understanding the substrate specificity of PTP's. The references for the General 
Introduction and the General Conclusions are found at the end of the dissertation. 
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CHAPTER 2. MUTATION OF RAT BRAIN PTP-1 SURFACE BASIC RESIDUES 
AFFECTS SUBSTRATE REACTIVITY 
A paper to be submitted to the journal Biochemistry 
Deborah S. Baedke and Thomas S. Ingebritsen 
Abstract 
Previous work by others has demonstrated that, in general, protein tyrosine 
phsophatases (PTP's) exhibit increased reactivity toward substrates containing 
acidic residues N-terminal to phosphotyrosine. Peptides from the in vitro 
phosphorylation site of reduced, carboxymethylated and maleylated lysozyme, with 
sequence modifications, were used as substrates. We show that substrates 
containing a single acidic residue C-terminal to the phosphotyrosine enhanced 
reactivity with rat brain PTP-1 (rbPTP-1). The greatest effect on reactivity was 
observed with a substrate aspartate residue at the P+2 position, which exhibited a 
3.3-fold increase in reactivity. Surface basic residues of rbPTP-1 were investigated 
for their role in the increased reactivity due to substrate acidic residues. Mutation of 
R47 or K120 to alanine decreased the enhancement of reactivity due to acidic 
residues N-terminal to phosphotyrosine by 78% and 73% respectively compared to 
WT. R47A or K120A mutants also demonstrated decreased PTP reactivrty with 
substrates containing an acidic residue C-temiinal to phosphotyrosine, 69% and 
52%, respectively. Mutation of both PTP residues resulted in almost complete 
abrogation of the substrate enhancement due to substrate acidics, decreasing 
substrate reactivity 91% and 89% due to N-temninal and C-terminal substrate acidic 
residues, respectively. Mutation of R24 or K36 to alanine had a smaller effect on the 
enhancement of substrate reactivity due to substrate acidic residues, decreasing 
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enhancement of reactivity 38% and 41% for R24A, and 49% and 48% for K36 with 
N- and C-temninal acidic residues, respectively. In all cases, kinetic analysis showed 
that the changes in reactivity primarily affected the Km only. The reactivity with 
rbPTP-1 of substrates containing acidic residues at different positions relative to 
phosphotyrosine was also altered by mutation of R47 and K120. WT and mutant 
PTP's both demonstrated additivity of the enhancment effect, but R47A and K120A 
mutants exhibited no difference in reactivity enhancement with substrates containing 
a single substrate acidic residue at position P-1 or P-5 relative to phosphotyrosine. 
These results suggest a general type of interaction between substrate acidic 
residues and PTP basic residues. 
Introduction 
Protein tyrosine phosphatases (PTP's) are enzymes that catalyze the removal 
of phosphate from phosphotyrosyl residues in proteins (Ingebritsen et al., 1994; 
Zhang & Dixon, 1994). These enzymes have been shown to be involved in many 
different cellular processes, including lymphocyte activation (Trowbridge & Thomas, 
1994), cell cycle progression (Dunphy & Kumagai, 1991; Gautier et al., 1991), and 
mitogenesis (Feng & Pawson, 1993; Sun et al., 1995). 
PTP-1B is a PTP that exhibits a wide distribution in tissues and organisms. It 
was originally purified from human placenta as a soluble enzyme (Tonks et al., 
1988), but is nonnally found in a membrane-bound form in many cell types (Pallen et 
al., 1991). Homologs of this enzyme have been cloned from human placenta 
(Chemoff et al., 1990; Brown-Shimer et al., 1990) and rat brain (Guan et al., 1990). 
The rat brain fomi, used In this study, is 97% identical to the human placental form in 
the first 323 amino acids, which encompasses the catalytic domain. A C-terminal 
hydrophobic domain targets human PTP-1 B to the endoplasmic reticulum (Frangioni 
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et al., 1992); similar localization was observed for rbPTP-1 (Woodford-Thomas et al., 
1993; Mauro et al., 1993). Also, the activity and localization of the protein may be 
regulated by proteolysis of the C-temninal tail of the protein, resulting in in-eversible 
translocation of the protein into the cytoplasm and an increase in activity (Frangioni 
et al., 1993). A second isofonn of the protein may arise by growth factor-dependent 
alternative splicing of the pre-mRNA, resulting in proteins differing in the last 7 C-
terminal amino acids (Shifrin & Neel, 1993); the C-terminus of the alternatively-
spliced product exhibits striking similarity to the C-temiinus of rat brain PTP-1 
(Woodford-Thomas et al., 1993). PTP-1 B has been implicated in regulating platelet 
activation (Frangioni et al., 1993) and in modulating insulin signaling (Goldstein, 
1993). 
Rat brain PTP-1 has been shown to dephosphorylate a wide variety of 
substrates in vitro. In particular, substrate acidic residues N-terminal to the 
phosphotyrosine significantly increased reactivity of peptide substrates with the 
enzyme (Hippen et al., 1993; Zhang et al., 1993). The increase in reactivity due to 
substrate acidic residues was due to a decrease in Km, with only small effects on 
Vm. In addition, acidics at positions P-1, P-2, and P-5 relative to the 
phosphotyrosine (where phosphotyrosine is position 0, and residues N-temiinal are 
denoted by P-X, and residues C-terminal are denoted by P+X) all increased 
reactivity with rbPTP-1, indicating broad positional effects of the substrate acidic 
residues. Multiple substrate acidic residues caused an additive effect on the 
reactivity enhancement. The charge of the acidic residues is also important in the 
effect; substitution of aspartate(s) with asparagine(s) resulted in a significant 
decrease in reactivity with rbPTP-1. These results indicate that substrate acidic 
residues may mediate specific interactions with the enzyme. The presence of 
substrate acidic residues has also been shown to enhance reactivity with LAR, 
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HPTPP (Cho et al., 1993), the T-cell phosphatase (Ruzzene et al., 1993) and YOP-
51 (Zhang et al., 1993), suggesting that substrate acidics may be a genera! 
component of the recognition sequence for PTP's. 
The crystal structure of PTP-1B has shown the position of the active site, and 
the position and possible interactions between the enzyme and the phosphate 
moiety of the substrate (Barford et al., 1994). The electrostatic surface of the 
structure revealed groups of basic residues near the active site that could potentially 
mediate the stimulation of reactivity due to substrate acidic residues. Because the 
presence of acidic residues in peptide substrates increased reactivity with rbPTP-1, 
and because the effect was dependent on the charge of the residue, we hypothesize 
that PTP surface basic residues, as shown in the crystal structure, may interact with 
substrate acidic residues to increase peptide reactivity. To test this hypothesis, we 
perfomned a mutational analysis of these enzyme basic residues. 
Experimental Procedures 
Materials. Taq polymerase and restriction enzymes were purchased from 
Promega. Oligonucleotide primers were synthesized at the ISU Sequencing and 
Synthesis Facility by using standard P-cyanoethylphosphoramidite chemistry on an 
Applied Biosystems 394 DNA Synthesizer (Foster City, CA). Triton X-100 and 
bovine serum albumin (BSA) were purchased from Boehringer Mannheim. Peptides 
used as substrates were synthesized by the iSU Protein Facility as previously 
described (Hippen et al., 1993). p2p]-y-ATP was purchased from ICN. All other 
chemicals were purchased either from Sigma or Fisher. 
Mutagenesis. The rat brain PTP-1 clone pKG-PTPU323 was a generous gift 
from Dr. Jack Dixon. Site-directed mutagenesis was perfomned by PGR (Higuchi, 
1990), with some modifications. Briefly, DNA fragments were generated that 
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corresponded to the N- and C-terminal portions of the PTP protein; the mutation was 
placed at the end of each fragment, such that they would overlap. The 
oligonucleotide sequences used are shown in Table 2.1. In some cases, a single 
base was changed to adenosine, to accommodate the addition of adenosine to the 3' 
end of the PGR product by Taq polymerase (Kuipers et al, 1991; Clark, 1988) The 
base change did not affect the amino acid at that position. Fragments were 
generated in separate 100 jiL PGR reactions containing 10 mM Tris-HGI, pH 8.4, 
0.75 mM MgGIa, 0.1 mg/mL BSA, 50 jiM each dNTP, 40 pmoles each one end 
primer, and the con-esponding mutant primer (each primer pair primes con-esponding 
coding and non-coding strands), 1 ng WT template, and 1U Taq polymerase. PGR 
was performed for 30 cycles with conditions for each cycle: 93oG 30 sec, SS^C 2 
min, 720C 1 min, and a final 10 minute incubation at 72oG. The R47A/K120A double 
mutant fragments were generated by using the R47A mutant full-length fragment for 
the template, and K120A mutant primers. Fragments were purified by either 
Geneclean (Bio 101, La Jolla, GA), or Magic prep kit (Promega). The full-length 
DNA fragment was generated by a second PGR reaction containing 40 pmoles of 
each end primer and both half fragments (but no WT template) using the same 
conditions as above. For the K36A and R47A mutants, PGR mutagenesis was 
perfomned using a single mutant template as previously described (Landt et al., 
1990). In the second PGR step, 0.1 ng WT template and all of the mutant fragment 
from the first PGR step were used. Using this method, however, we found an 
extrordinarily high frequency of WT amplifications and secondary base 
misincorporation, and so used the first method for the majority of the mutants. Full-
length inserts were purified by Geneclean, cut with Hindlll and EcoRI, ligated into the 
vector pGEX-KG, and transfomned into E. coli using standard molecular biology 
techniques. Recombinant plasmids were screened by agarose gel electrophoesis of 
Table 2.1. Primer sequences used for PGR mutagenesis. 
Primer Sequence 
End primers 5'a 5'>GTGGTGGAATTCGCGCCCAA 
3' 5'>CCTCAAAGCTTTCCTCGCTCACCCA 
Mutaaenic Drimers" Coding Strand Noncoding Strand 
R24A 5'>AATGCACATGAAQCCAGTGAC 5'>GGCTTCATGT<3GAATATCCTGGTA 
K36A 5'>AGCGfiGACTTCCTAAGAACAAc 
R43A 5'>AAAAACfiGGAACAGGTACCGAGAT b'>ACCIGriC15CGI 1 NIG"! IGITAGG 
R45A 5'>AACfi£GTACCGAGATGTCAGC 5'>GACATCTCGGTACfi£GTTACGGTTTTTG 
R47A 5'>AGGTACfi£AGATGTCAGCCCTTTc 
K116A 5'>GGAGfi£AGGCTCGTTAAAATG 5'>AACGAGCCTfi£CTCCATGATGCG 
K120A 5'>CGTTAfiGATGTGCCCAGTATTG 5'>GCACATGCTAACGAGCCTTTC 
R254A 5'>GTTGGAGATGfiGCAGATTCCGCA 5'>GTGGCCATCTCCAACAGCAC 
Seauencina orlmers Sequence 
nt-50" 5'>GCATGGCCTTTGCAGGG 
nt 205 5'>CCAGAGQAGCTATATCC 
nt 489 5'>CGAGAGATCCTGCATTTC 
nt 775 5'>CCGACCAACTGCGCTTC 
85' primer corresponds to the EcoRI restriction site and primes the coding strand. 3' primer primes 100 bp downstream 
of the stop codon at amino acid 323 on the noncoding strand, and introduces a Hindlll restriction site into the fragment; 
restriction sites indicated by underlining. 
•^Mutations are indicated by bold and underlining. 
^Mutagenesis done as described in Landt et al., 1990; see Experimental Procedures for details. 
''"nt" corresponds to the number of the first nucleotide where primer binds, where 0 is the 5" EcoRI restriction site, nt-50 
is 50 nt upstream of the EcoRI cloning site on the pGEX-KG plasmid 
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purified plasmids cut with Hindlll and EcoRI. Plasmid templates were prepared 
using the Qiagen plasmid purification kit (Chatsworth, CA), and sequenced by the 
ISU DNA Sequencing Facility as described (Frothingham et al., 1994), except that 
the PGR conditions used were an initial preincubation at 95oC for 3 min, and cycling 
parameters of 98oC for 15 sec, SQoC for 10 sec, and 60oC for 4 min. The entire PTP 
coding region was sequenced to verify the presence of only the mutation of interest. 
Sequences of primers used for sequencing are shown in Table 2.1. 
Protein expression and purification. Wild-type and mutant proteins were 
expressed and purified as previously described (Guan & Dixon, 1991). During the 
purification, PTP activity was monitored by pNPP activity assays as previously 
described (Hippen et al., 1993). After thrombin cleavage, PTP's were dialyzed into 
50 mM imidazole, pH 7.0, 50% glycerol, 2 mM EDTA, and 0.1% 2-mercaptoethanol 
and stored at -20oC. 
Substrate preparation. Peptides were phosphorylated and HPLC-purified as 
previously described (Hippen et al., 1993). A recombinant p-insulin receptor kinase 
(BIRK) was used to phosphorylate the peptides; BIRK was expressed and purified 
through the Separose Fast-Q step as previously described (Herrera et al., 1988). 
Enzyme characterization. PTP assays were performed as previously 
described (Hippen et al., 1993) using either pNPP or 32p.phosphopeptides as 
substrates. For peptide substrates, assays were stopped by the addition of acidic 
charcoal solution (Krueger et al., 1990). Protein concentration was determined as 
previously described (Bradford, 1976). 
Data analysis. Apparent Km and Vm values of selected mutants were 
determined as previously described (Hippen et al., 1993). For all of the kinetic 
parameters, three independently purified preparations of each PTP were used for 
the assays, and the uncertainty was estimated by calculating the SEM of the three 
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preparations witin each substrate. Statistical analysis was performed using the 
Student t test. 
Results 
C-terminal substrate acidic residues increase reactivity with wild-type 
rbPTP-1. Previous kinetic evidence with rbPTPI suggested that this enzyme 
exhibits broad positional specificity with substrates containing acidic residues; 
acidics at position P-5, P-2, and P-1 all increased reactivity of the PTP with substrate 
(Hippen et al., 1993) (where phosphotyrosine is position 0, and residues N-temninal 
are denoted by P-X, and residues C-terminal are denoted by P+X). To investigate 
this further, kinetic analysis was perfomned using RCML-related peptides containing 
a single aspartate at each position in the sequence, shown in Figure 2.1. rbPTP-1 
exhibited increased substrate reactivity with substrates containing C-terminal acidics 
relative to phosphotyrosine. Stimulation of reactivity occun'ed when a single acidic 
residue was at the P+2 or P+3 position. The greatest stimulation in reactivity 
occurred with a substrate acidic at the P+2 position (a 2.5-fold effect). The enzyme 
also exhibited broad substrate reactivity when acidics were N-terminal to the 
phosphotyrosine. 
Effect of R47A and K120A mutations on PTP reactivity due to substrate 
acidic residues. Effect of N-terminal substrate acidic residues. The crystal 
structure of PTP-1 indicated three groups of surface basic residues close to the 
active site that could interact with substrate acidic residues (Figure 2.2 and Barford 
et al., 1994). To investigate whether these basic residues are involved in the 
enhancement of substrate reactivity caused by substrate acidic residues, these 
residues were singly mutated to alanine. The mutant proteins were expressed and 
purified as described in the Experimental Procedures. The effect of acidic residues 
Figure 2.1. Positional specificity of WT rat brain PTP-1. Values are expressed as 
the ratio of Vm/Km for substrates containing an aspartate at the indicated positions 
versus the peptide Ac-ATAGSTApYGlL-NH2 for the N-terminal acidics, or 
NTAGSTApYGILQI for the C-terminal acidics. Position 0 is the phosphotyrosine. 
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position relative to tyrosine 
Figure 2.2 Diagram fo the surface basic residues of human placental PTP-1B 
(Brookhaven protein database #2hnp). Diagram depicts the surface basic 
residues R47 (top, left open arrow), K120 (bottom, right open an-ow), K36 (left, 
closed an-ow), R24, (right, closed arrow), and clockwise from the top, R254, 
K116, R45, and R43. The active site cysteine (C215) is denoted by the asterisk. 
Diagram was generated using Rasmol. 
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on the activity of the PTP-1 wild-type (WT) and mutant enzymes was assessed by 
comparing the ratio of Vm/Km (a measure of the substrate reactivity) of a peptide 
substrate containing a single aspartate residue at P-2 or P+2 position to a peptide 
containing no acidic residues (Figure 2.3). This ratio is a measure of the stimulation 
in PTP activity caused by the presence of acidic residues in the substrate. 
Mutation of PTP-1 residues R47 or K120 to alanine markedly decreased the 
stimulation of reactivity by substrate acidic residues (Figure 2.3). An aspartate at P-
2 relative to the phosphotyrosine stimulated reactivity with the WT enzyme 4.2-fold 
compared to a peptide containing no acidic residues. Note that a value of 1 is no net 
reactivity enhancement due to acidic residues. When R47 was mutated to alanine, 
the stimulation in reactivity due to an acidic residue at the P-2 position decreased 
from 4.2 to 1.7-fold. Stimulation by a P-2 acidic residue decreased by 78%. 
Mutation of K120 to alanine showed a similar effect; the stimulation of reactivity due 
to a P-2 acidic residue decreased to 1.9-fold, accounting for a 73% reduction in 
reactivity compared to WT. 
Because each basic residue mutation separately caused only a partial 
reduction in the stimulation of substrate reactivity due to acidic residues, it was of 
interest to determine whether the two residues cooperate in enhancing PTP activity 
due to the acidic residues. To detemiine if this is the case, the R47A/K120A double 
mutant was prepared, and its kinetic parameters were determined as above. The 
stimulation of reactivity due to substrate acidic residues was almost completely 
abolished with the double mutant; stimulation of reactivity was reduced from 4.2 to 
1.3-foId with a peptide containing a single aspartate at P-2. This accounted for a 
91% decrease in the stimulation compared to the WT. 
Previous kinetic evidence with the WT enzyme demonstrated that the 
stimulation in reactivity due to acidic residues was due to a decrease in Km of the 
Figure 2.3. Mutations in rbPTP-1 affect substrate reactivity enhancement by 
substrate acidic residues. Values are expressed as the mean±SEM of the ratio of 
Vm/Km for the P-2 (solid bars) or P+2 (open bars) acidic peptide versus the peptide 
containing no acidic residues. p>0.005 versus WT (*) and p>0.0005 versus WT (#) 
indicate statistical significance. 
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substrate with no effect on the Vm (Hippen et al., 1993; Zhang et al., 1993). 
Comparison of the i<inetic parameters of these three mutants with WT shows that the 
majority of the change in reactivity between mutant and WT PTP's is due to the Km 
(Table 2.2). An aspartate residue at the P-2 position reduced the Km of the WT 
enzyme from 7.4 p.M with the control peptide to 1.7 p.M, a 75% decrease. In 
contrast, the effects of the substrate acidic residue on the Km were much smaller for 
both R47A and K120A. For R47A, an aspartate at the P-2 position decreased the 
Km from 14.6 n-M to 8.5 iiM, a reduction in the Km of only 42%. A similar result was 
seen for the K120A mutant; an aspartate at the P-2 position reduced the Km from 
3.7 |iM to 2.5 (i.M, only 33%. The change in the Km due to acidic residues was even 
smaller for the R47A/K120A mutant; the Km decreased only 5%, from 10.6 nM to 
10.0 jiM. Jn contrast, there were no significant differences in Vm between substrates 
for each enzyme. Because only the Km for the acidic peptides is affected by the 
mutations, enzyme basic residues may be involved in the same manner as the 
substrate acidic residues in stimulating substrate reactivity, most likely by direct 
interaction between substrate and PTP residues. 
Substrate C-terminal acidic residue effects. PTP basic residue mutations also 
affected the stimulation in substrate reactivity due to substrate C-terminal acidic 
residues. As shown in Figure 2.1, the greatest effect in WT stimulation on the C-
terminal side was observed at the P+2 position. With the WT enzyme, reactivity with 
a peptide containing an acidic residue at the P+2 position stimulated reactivity 3.3-
fold over a control peptide (Figure 2.3). Mutation of R47 or K120 reduced the 
enhancement of reactivity due to C-terminal acidic residues. When R47 is mutated 
to alanine, the stimulation of reactivity due to a P+2 aspartate residue decreased 
from 3.3-fold to 1.7-fold, a 69% reduction compared to WT. The effect of the 
mutation at K120 on stimulation of peptide reactivity was similar; the enhancement of 
Table 2.2. Kinetic parameters of rat brain PTP-1 mutants  ^
wr R47A K120A R47A/K120A R24A K36A 
Vm/Km nob 3.3 ±0.4 4.0 ±0.8 2.0 ±0.4 0.58 ±0.07' 1.5 ±0.3® 5.6 ±2.0 
P-2 13.8 ±1.8d 6.8 ±1.3 3.3 ±0.6 0.75 ±0.05 4.6 ±1.3° 14.5 ±5.3 
P+2 11.1 ±1.8d 6.9 ±1.4 4.4 ±1.3 0.75 ±0.11 3.7 ±1.2 12.1 ±4.3 
Km no 7.4 ±0.5 14.6 ±1.9' 3.7 ±1.00 10.6 ±1.0® 13.1 ±4.5 7.9 ±0.9 
P-2 1.7 ±0.0  ^ 8.5 ±0.7d 2.5 ±1.0 10.0 ±0.5 5.8 ±2.7 3.4 ±0.6d 
P+2 2.8 ±0.1d 11.3 ±2.2 2.2 ±0.7 6.6 ±1.4c 8.8 ±4.5 4.5 ±0.6° 
Vm no 24 ±2 62 ±17° 6.7 ±0.9' 6.2 ±1.1' 16 ±1® 48 ±18 
P-2 23 ±3 60 ±13 7.3 ±2.0 7.4 ±0.2 20 ±1° 57 ±24 
P+2 31 ±5 85 ±28 8.2 ±1.3 4.7 ±0.2 22 ±1° 59 ±23 
pNPPg 25 ±1 48 ± 90 15 ±36 7.4 ±1.6' 18 ±3® 30 ± 8 
^Values are expressed as the mean+SEM for separate determinations using three independent PTP preparations. 
The Vm value for each mutant was normalized to the pNPP specific activity measured when the enzymes were 
purified. Vm units are (imoles Pi released / min / mg protein. Km units are |xM. Statistical analysis was done using 
the Student t test. 
^peptide substrate sequences: no, AcATAGSTApYGIL-NH2: P-2, AcATAGSDApYGIL-NHa: P+2, 
AcATAGSTApYGDL.NH2. 
p values versus no acidic peptide are: cp>0.05: ^ p>0.005. p values versus WT with no acidic peptide (or pNPP in 
last row) are: ®p>0.05; 'p>0.001. 
sValues of pNPP activity are Initial velocity determinations performed using 15 mM substrate, as described in the 
Experimental Procedures. 
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reactivity decreased from 3.3-fold to 2.1-fold, accounting for a decrease of 52% 
compared to WT. Because each mutation also demonstrated a partial loss in the 
ability of C-temiinal acidic residues to stimulate reactivity, the double mutant was 
also tested for the ability of the P+2 acidic peptide to stimulate reactivity. The 
stimulation in reactivity due to a substrate C-teoninal acidic residue was almost 
completely abolished with the double mutant. The stimulation in reactivity dropped 
from 3.3-fold to 1.3-fold, an 89% reduction compared to the WT. 
Comparison of the kinetic parameters demonstrated that the mechanism for 
the change in stimulation due to the basic residue mutations is similar for the P+2 
substrate acidic position as for the P-2 position; the Km is affected, while no change 
in the Vm was detected (Table 2.2). For the WT enzyme, the Km for a P+2 acidic 
peptide decreased 62%, from 7.4 iiM for the control peptide to 2.8 |xM. Both single 
mutant enzymes demonstrated a greatly reduced effect of the P+2 acidic peptide on 
the Km. The Km for R47A decreased only 23%, from 14.6 |iM for the control peptide 
to 11.3 fiM. When K120 was mutated to alanine, the effect of the P+2 acidic peptide 
on the Km was also reduced; the Km decreased 41 %, from 3.7 jiM for the control 
peptide to 2.2 jiM. Mutation of both R47 and K120 reduced the effect on the Km 
similarly; a P+2 acidic peptide decreased the Km 38%, from 10.6 p,M to 6.6 fiM. In 
contrast, there were no significant changes in Vm between substrates for each 
enzyme. 
Mutation of R47 or K120 to alanine produced some minor changes in basal 
reactivity towards pNPP and a peptide substrate containing no acidic residues 
(Table 2.2), suggesting that these mutations may have subtle effects on the 
conformation of the enzyme. With pNPP, the single mutations changed the specific 
activity up to 2-fold. The PTP mutations also changed the Vm/Km of the peptide 
containing no acidic residues up to 2-fold compared to WT. These small changes in 
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reactivity may reflect subtle effects of the mutations on binding the phosphotyrosine 
substrate determinant, or effects on PTP conformation that affect catalysis. Mutation 
of both R47 and K120 caused a 5-fold effect on pNPP and peptide substrate activity, 
suggesting a cumulative effect of the mutations on substrate binding or catalysis. 
However, the ratio of pNPP-to-control peptide specific activity (a measure of base 
substrate binding not due to amino acid side chains) demonstrated that the effects of 
the mutations on PTP-substrate interactions are similar for both pNPP and peptide 
substrates. There was no significant difference between WT and each mutant in this 
ratio (data not shown), suggesting that the base substrate reactivity not due to acidic 
residues is not affected by the mutations. 
The effect of R24A and K36A mutations on substrate reactivity. Two 
other residues found on the PTP surface near the active site are R24 and K36 
(Figure 2.2 and Barford et al., 1994). These residues are both located farther away 
from the active site than are R47 and K120. K36 and R24 are situated on the 
opposite side of the active site from K120, and on either side of R47. Both the R24A 
and K36A mutants each demonstrated a decrease in the stimulation of reactivity due 
to substrate acidic residues, but the effect of these single mutations was not as great 
as the effect of the R47A or K120A mutations (Figure 2.3). When R24 was mutated 
to alanine, the stimulation in substrate reactivity due to a P-2 aspartate dropped from 
4.2-fold for the WT to 3.0-fold, a 38% decrease in stimulation. Mutation of K36 to 
alanine had a similar effect; the stimulation of substrate reactivity due to a P-2 
substrate acidic residue was reduced 49%, from 4.2-fold to 2.6-fold. The presence 
of the R24A or K36A mutation had a similar effect on decreasing reactivity with 
substrates containing an acidic residue at the P+2 position . Substrate reactivity with 
R24A decreased from 3.4-fold to 2.4-fold, a 41% reduction compared to the WT. 
With K36A, the substrate reactivity was reduced to 2.2-fold, a 48% decrease. 
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Comparison of kinetic parameters between substrates demonstrated that the 
majority of the change in substrate reactivity is due to chariges in Km, with no 
change in Vm, as shown with the other mutants (Table 2.2). For the WT, the Km for 
the P-2 peptide decreased 77% compared with a control peptide. The Km of the 
R24A mutant for the peptide containing an aspartate at the P-2 position decreased 
only 56%, from 13.1 jiM to 5.8 |iM. Similarly, the Km of K36A decreased only 57%, 
from 7.9 |xM to 3.4 jiM. These values show an intermediate effect on substrate 
reactivity between WT and the R47A and K120A mutants. In contrast, there were 
only minor changes in Vm between the two substrates for both mutants, as seen 
with the WT. 
Mutation of R24 and K36 resulted in a similar reduction in substrate reactivity 
enhancement due to C-terminal acidic residues (Figure 2.3). For R24A, stimulation 
of reactivity due to a P+2 acidic dropped from 3.3-fold to 2.4-fold, a 41% reduction 
on stimulation compared to WT. Similarly, the stimulation of reactivity with K36A 
decreased 38%, from 3.3-fold for WT to 2.2-fold. We also observed a similar effect 
on the mutant Km for the substrate containing a P+2 acidic residue as for a P-2 
acidic residue, with no change in Vm (Table 2.2). For WT, the Km decreased 62%, 
fornn 7.4 jiM to 2.8 |iM. In contrast, the Km for R24A decreased from 13.1 |iM to 8.8 
jiM with the P+2 peptide, only a 33% reduction. For K36A, the Km decreased only 
43%. from 7.9 jiM to 4.5 jiM. As with the P-2 peptide, there were only minor 
changes in the Vm between peptide substrates for both mutants. These results 
suggest that R24 and K36 do affect substrate reactivity due to acidic residues using 
a mechanism similar to R47 and K120. However, R24 and K36 have a smaller role 
in the stimulation of substrate reactivity. 
Basal substrate reactivity and catalytic ability were not affected by the R24A 
or K36A mutations (Table 2.2). The ratio of pNPP/control peptide activity was also 
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unaffected by the mutations (data not shown), suggesting that the mutations 
probably are not affecting the confonnation of the mutant enzyme. In addition, the 
pNPP specific activity and Vm/Km for the control peptide were similar to the WT 
values. 
PTP mutational effects on substrate acidic positional specificity and 
additlvity. WT PTP-1 shows broad positional specificity of substrate acidic residues 
both N- and C-terminal to the phosphotyrosine {Figure 2.1 and Hippen et a!., 1993). 
If specific charge-charge interactions are responsible for the increased peptide 
reactivity, then mutation of residues in the PTP should change the positional 
specificity seen with the WT enzyme. To test if this is the case, the initial rates of the 
mutant and WT enzyme activities were compared with substrate peptides containing 
either a single aspartate at the P-5 or P-1 position, aspartates at both positions, or 
alanines at both positions. The activities were expressed as ratios of aspartate-
containing peptide activity to alanine-containing peptide activity to detennine the 
amount of stimulation in peptide reactivity. 
As demonstrated in Figure 2.1, a single substrate acidic at P-2 had a greater 
effect on activity enhancement with the WT enzyme than a single substrate acidic at 
P-5 or P-1 (5.5-foid versus 3.0-fold and 2.3-fold, respectively). When R47 or K120 is 
mutated to alanine, however, the positional specificity observed with the WT is lost. 
The level of substrate activity enhancement observed with a P-5 or P-1 acidic with 
either mutant (approximately 1.6-fold, Figure 2.4) is strikingly similar to the level of 
enhancement due to substrate acidics at P-2 or P+2 seen in Figure 2.3 (from 4.1-
and 3.3-fold respectively, with WT to 1.6-fold with either mutant). The reason for this 
is unclear. The R24A mutant also exhibited a decrease in substrate reactivity 
relative to WT with all peptides (19.5%, and 27.8% decrease with substrate acidics 
at P-5, or P-1, respectively). However, the decrease in reactivity seen with the R24A 
Figure 2.4. Positional effects of substrate acidic residues on mutant PTP activity. 
Values are expressed as the ratio of initial velocity measurements of substrates 
containing acidic residues at P-5/P-1 (solid bars), P-5 (open bars) or P-1 (shaded 
bars) versus a peptide containing alanine at both positions. The substrate 
concentration used was 0.5 mM. Initial velocities were normalized to the pNPP 
activity measured when the enzymes were purified. p>0.005 versus P-5/P-1 peptide 
(*) and p>0.0005 versus P-5/P-1 peptide (#) indicate statistical significance. 
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mutant was less than that observed with either R47A or K120A, suggesting that R24 
has a smaller effect on the enhancement of reactivity due to substrate acidic 
residues. 
The enhancing effect of substrate acidic residues is additive for all the 
enzymes, in that two substrate acidics have a greater effect on the enhancement in 
PTP reactivity than a single acidic. With the WT, this confinns previous kinetic data 
(Hippen et al., 1993). That an additive effect still occun-ed when R47 or K120 was 
mutated suggests that each PTP basic residue may interact in some manner with 
both substrate acidic residues to cause the increased reactivity with this substrate. 
However, both observations with the R47A and K120A mutants (effects on additivity 
and effects on positional specificity) suggest that a specific charge-charge interaction 
between substrate acidic and PTP basic residue may not be responsible for the 
enhancement in PTP reactivity due to substrate acidic residues. 
Other PTP mutations. Other basic residues near the active site of PTP-1 
that may participate in the reactivity of substrate acidic residues are R43 and R45, 
located near K36, and R254, located near R24 in the crystal structure (Barford et al., 
1994 and Figure 2.2). Proteins containing these single mutations had altered 
characteristics that were discovered during various screens to select against 
enzymes that exhibited non-WT behavior; enzymes so selected were not analyzed 
further. One criterion used was if the mutant expressed in E. col'r, the K116A mutant 
did not express using WT expression conditions. The second criterion used was 
near-WT pNPP activity; the R43A mutant exhibited approximately 100-fold lower 
activity than the WT. The third criterion used was the peptide/pNPP specific activity 
ratio, as a measure of the effects of mutations on substrate interaction not due to 
peptide acidic residues. Both R45A and R254A demonstrated a decrease in this 
ratio compared to the WT (6.6 and 5-fold, respectively). 
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Discussion 
Previous work by others has shown that N-terminal acidic residues can 
increase substrate reactivity with many different PTP's (Hippen et al., 1993; Zhang et 
a!., 1993; Ruzzene et a!., 1993; Cho et a!., 1993). Here we show that substitution of 
amino acids C-terminal to phosphotyrosine with an acidic residue also increases 
reactivity with rat brain PTP-1. We also confimi the broad positional specificity due 
to N-temninal acidic residues; a single acidic residue in position P-1 to P-5 all 
increase reactivity with rbPTP-1. While the effect of C-terminal substrate acidics is 
not as large as acidics N-terminal to phosphotyrosine, they may subtly influence 
substrate reactivity in physiological substrates. Comparison of the relative reactivity 
of a panel of peptides based on in vivo phosphorylation sites demonstrated that 
more highly reactive peptides contained N-and C-terminal acidic residues within 5 
amino acids of the phosphotyrosine (Hippen, 1993). In addition, relatively poor 
substrates in this panel contained N- and/or C-terminal basic residues. Substitution 
of the P-3 aspartate in the abl kinase phosphorylation site (Y393) with lysine 
decreased reactivity 12-fold with the T-cell phosphatase, indicating that substrate 
basic residues may serve a function opposite that of acidic residues, as negative 
detemiinants for substrate reactivity (Ruzzene et al., 1993). 
Here we also show that mutation of PTP surface basic residues R47, K120, 
R24, and K36 to alanine specifically affects the enhancement of reactivity due to 
substrate acidic residues. The greatest effect of the mutations was with R47A and 
K120A, where mutation of both residues eliminated 90% of the stimulation of 
substrate reactivity caused by substrate acidic residues. Mutation of R24 and K36 to 
alanine had a much smaller effect on the substrate acidic stimulation of reactivity 
than the other two mutations. We also show that R47A and K120A single mutations 
not only decrease the reactivity enhancement due to single substrate acidics, but 
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also abrogate the relative preference for acidic residues P-1 versus P-5 that was 
observed with the WT. Interestingly, these mutations did not affect the additivity of 
reactivity enhancement due to multiple substrate acidic residues. 
These results indicate that PTP basic residues most likely have a more 
general effect on substrate reactivity than specific interactions. These potential 
interactions can only be inferred from the data presented, but the results do suggest 
a more general effect of the PTP basics. In particular, the R47A or K120A mutation 
both affected the positional specificity of the substrates (by decreasing reactivity 
enhancement with P-1 and P-5 single substrate acidics) without affecting relative 
additivity. In addition, the R24A mutation did not significantly decrease the 
enhancement of reactivity with a peptide containing a P-5 acidic residue. If a 
specific ion-pair interaction were responsible for the reactivity enhancement, then 
one would expect R47 and/or K120 to mediate the effect of acidics closer to 
phosphotyrosine, and K36 and/or R24 to mediate the effect of acidics farther away 
from the active site, given their positions on the PTP-1B surface. Also, that the 
double mutant (R47A/K120A) eliminated 90% of the reactivity enhancement due to a 
single substrate acidic also suggests that R47 and K120 work together to mediate 
the substrate acidic residue effect on reactivity enhancement. 
The enhancement in reactivity caused by substrate acidic residues differs 
depending on both the enzyme studied and the peptides substrate sequences used. 
When the same peptide substrates are used, the positional effect of acidic residues 
is much broader for rbPTP-1 and YOP-51 than for CD45 and LAR. Also, the 
magnitude of the effect is greater for rbPTP-1 than for CD45 and LAR (Hippen, 
1993). Although part of the differences in reactivity may be due to the use of artificial 
substrates, comparison of primary sequences suggests that other PTP's may have 
fewer surface basic residues which could mediate the effect of substrate acidic 
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residues. PTP-1 contains surface basic residues at amino acids 24, 36, 47, and 
120. In many of tiie other PTP's cloned thus far, K120 is highly consen/ed (Krueger 
et al., 1990, Zhang & Dixon, 1994). However, R24, K36, and R47 are divergent in 
most of the cloned PTP sequences examined. In particular, CD45 and LAR both 
contain non-polar residues at position 47 (valine and alanine, respectively); HPTPp 
contains an asparagine at this position. These enzymes also exhibit a reduced 
effect of substrate acidic residues on activity compared to rbPTP-1 (Cho et al., 1993; 
Hippen, 1993). The large effect that the PTP-1 R47A mutation has on substrate 
reactivity indicates that a basic residue at position 47 may be important in mediating 
the effects of substrate acidic residues. 
Additional evidence with PTP-PEST also suggests a role for R47 in substrate 
reactivity. PTP-PEST is phosphorylated on a serine residue in the analogous 
position of R47 in rbPTP-1. This phosphorylation event results in a decrease in 
enzyme activity, due kinetically to a decrease in Km (Garton & Tonks, 1994). The 
magnitude of the effect of phosphorylation of PTP-PEST is very similar to the effect 
of the R47A mutation on substrate reactivity with rbPTP-1, indicating that this relative 
position may be important in substrate interactions. 
Recently, the structure of PTP-1 B complexed to a phosphopeptide derived 
from the EGF receptor was published (Jia et al., 1995). The stmcture demonstrates 
interactions of R47 with N-temiinal substrate acidic residues. While the data 
presented here does not specifically address substrate binding, a study is in 
progress to specifically examine the effects of substrate acidic and PTP basic 
residues on binding interactions. 
Mutation of K116, R43, R45, and R254 to alanine all resulted in enzymes with 
altered catalytic and/or substrate reactivity characteristics. It is interesting to note 
that R45 and R254 are highly consented in ail PTP's (Kmeger et al., 1990; Zhang & 
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Dixon, 1994). Mutation of tiie iiomologous residues in YOP-51 (Zhang et al., 1994) 
and LAR (Cho et al., 1992) also resulted in nnutants with greatly reduced activity, 
indicating that these residues may be important in folding or stabilizing the general 
confomnation of PTP's. 
Summary. In summary, we show that mutation of R47 and K120 to alanine 
decreased the substrate specificity of rbPTP-1, and that this effect is due to a 
relative increase in the Km. Mutation of both R47 and K120 almost completely 
abrogates the effects of substrate acidics to enhance reactivity. Smaller effects on 
substrate reactivity due to substrate acidics were observed with PTP mutations of 
R24 and K36 to alanine. With WT or mutant enzymes, the presence of multiple 
substrate acidic residues is additive, but the position of the substrate acidic residue 
relative to phosphotyrosine did not affect the enhancement of substrate reactivity 
with the R47A or K120A mutants. 
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CHAPTER 3. SUBSTRATE BINDING TO RAT BRAIN PTP-1 IS ENHANCED BY 
SUBSTRATE ACIDIC RESIDUES 
A paper to be submitted to the journal Biochemistry 
Deborah 8. Baedke and Thomas 8. Ingebritsen 
Abstract 
Previous woi1< has shown that substrate acidic residues are important in 
increasing reactivity of substrates with protein tyrosine phosphatases. For rat brain 
PTP-1 (rbPTP-1), substrate acidic residues increase PTP reactivity; this reactivity 
enhancement was caused by substrate acidic residues both N- and C-tenninal to 
phosphotyrosine, and was enhanced by substrate acidic residues at many different 
positions relative to phosphotyrosine. The effect of substrate acidic residues on 
increasing reactivity is also additive. To examine the effect of substrate acidic 
residues on substrate binding, a cysteine-to-serine mutant of rbPTP-1 was used. 
This mutation resulted in a protein that, while enzymatically inactive, still possessed 
substrate binding ability. Peptide substrates demonstrated much higher affinity for 
PTP binding than para-nitrophenyl phosphate, a phosphotyrosine analog. 8ingle 
acidic residues at P-1, P-2, P-5, and P+2 relative to phosphotyrosine all increased 
the binding affinity of peptides for rbPTP-1 when compared to peptides without acidic 
residues. The effect of the number of acidics on binding was additive, in that a 
phosphopeptide containing two acidic residues showed higher affinity for the PTP 
than peptides containing either one or no acidic residues. These results indicate that 
the reactivity enhancement of rbPTP-1 due to substrate acidic residues is a direct 
binding effect. 
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Introduction 
Protein tyrosine phosphatases (PTP's) are enzymes that catalyze the removal 
of phosphate from phosphotyrosyl residues in proteins. This class of enzymes have 
important roles in the regulation of many cellular processes, including mitogenesis 
(Feng & Pawson, 1993; Sun et al., 1995), cell cycle regulation (Dunphy & Kumagai, 
1991; Gautier et al., 1991), insulin signaling (Goldstein, 1993), and lymphocyte 
activation (Trowbridge & Thomas, 1994). 
Using model substrates, many groups have demonstrated that, in general, 
PTP's are more reactive toward substrates that contain acidic residues (Hippen et 
al., 1993; Ruzzene et al., 1993; Cho et al., 1993; Zhang et al., 1993; Baedke & 
Ingebritsen, 1996). Substrate acidic residues show broad positional specificity; they 
enhance PTP reactivity at positions P-5, P-2, P-1 and P+2 relative to 
phosphotyrosine. The enhancement of PTP reactivity by substrate acidics is also 
additive. The kinetic effect of the substrate acidics was to decrease the Km 
approximately 2-3-fold without appreciably affecting the Vm, suggesting an effect of 
the substrate acidics on binding with the enzyme. 
The crystal structure of PTP-1B co-crystallized with the EGF receptor 
phosphorylation site peptide DADEpYL indicated that certain PTP surface residues, 
R47 in particular, make contacts with N-terminal substrate acidic residues (Jia et al., 
1995), suggesting that the effect of substrate acidic residues is in PTP binding. 
Similar observations of peptide-protein interactions have been noted with SH2 
domains co-crystallized with phosphopeptide (Waksman et al., 1992, Waksman et 
al., 1993; Eck et al., 1993; Pascal et al., 1994); some specificity in phosphopeptide 
recognition is due to specific interaction of SH2 domain amino acids with 
phosphopeptide side chains. Competition binding studies of SH2 domains using 
phosphopeptides have also demonstrated that SH2 domains can discriminate 
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between peptides based on their sequence (Zhu et al., 1994; Piccione et al., 1993; 
Maclean et al., 1995; Zhu et al., 1993; Zhu et al., 1992; Huyer et al., 1995). Despite 
the similarities between SH2 domain-peptide and PTP-peptide binding indicated by 
crystal structures and kinetics, the effect of peptide sequence on PTP-peptide 
binding has not been studied in detail. 
Mutation of the active site cysteine to serine results in an inactive protein; this 
inactive protein, however, retains its ability to bind phosphorylated proteins (Guan & 
Dixon, 1991a; Milarski et al., 1993; Sun et al., 1993; Maclean et al., 1995). This 
inactive enzyme can thus be used to probe the role of substrate and enzyme 
residues in substrate binding. In this paper, we demonstrate that rat brain PTP-1, a 
PTP-1B homolog, can discriminate between peptides based on sequence, and that 
substrate acidic residues enhance binding of substrates to rat brain PTP-1. 
Experimental Procedures 
Materials. Oligonucleotides were synthesized at the ISU Sequencing and 
Synthesis facility by using standard |3-cyanoethylphosphoramidite chemistry on an 
Applied Biosystems 394 DNA Synthesizer (Foster City, CA). Peptides were either 
synthesized at the ISU Protein Facility or obtained from Quality Controlled 
Biochemicals (Hopkinton, MA). pspj-y-Ajp was purchased from ICN. Bovine serum 
albumin and Triton-X100 were purchased from Boehringer Mannheim. Taq 
polymerase and restriction enzymes were purchased from Promega. All other 
chemicals were purchased from Sigma or Fisher. 
Peptide preparation. Phosphopeptides were either purchased from Quality 
Controlled Biochemicals (Hopkinton, MA) or phosphorylated and purified as 
previously described (Hippen et al., 1993) except that no [32P]-y-ATP was included in 
the reaction. Phosphopeptide peaks were quantified by running small aliquots of the 
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resuspended peptide over the HPLC and comparing peak height to a standard curve 
constructed with casein 121 peptide (NANEEEpYGlL). 32p_|abeled casein 121 
peptide was phosphorylated as previously described (Hippen et al., 1993) except 
that no unlabeled ATP was included in the reaction, and the radioactive peak was 
saved. 
Mutant PTP's. The C215S mutant of rbPTPI (designated "WT" in this paper) 
was prepared as previously described (Baedke & Ingebritsen, 1996), using as 
mutagenic primers 5'>CCAGCACTGG AGTGGACCACAAT and 
5'>CCACTCCAGTGCTGGAATTGG for the non-coding and coding strands, 
respectively. The Xhol-Hindlll fragment containing the mutation was sequenced at 
the ISU Sequencing Facility as previously described (Baedke & Ingebritsen, 1996) 
For the mutants R47A/C215S, R47A/K120A/C215S, and K120A/C215S, the Xhol-
Hindlll fragment from each of the other mutants corresponding to the 3' portion of the 
coding region was replaced with the fragment containing the C215S mutation, using 
standard molecular biology techniques. Mutant proteins were expressed as GST 
fusion proteins and purified as previously described (Guan & Dixon, 1991b), except 
that fusion proteins were eluted from the GSH-agarose by washing twice with 1 mL 
10 mM glutathione for 10 minutes. Fusion proteins were dialyzed into 50 mM 
imidazole pH 7.0, 0.05 mM EDTA, 0.1% 2-ME , 50% glycerol and stored at -20°C 
until assaying. Protein concentration was detemnined as described (Bradford, 1976). 
Binding assays. Binding assays were done essentially as described 
previously (Piccione et al., 1993). In brief, in a 100 jxL reaction, 35 fmoles 32p-
casein peptide, various amounts of unlabeled competitor, and 0.25 \iM GST-FTP in 
PAB (50 mM Tris-HCI pH 7.0, 0.05 mM EDTA, 0.1% 2-ME, 1 mg/mL BSA) were 
incubated for 10 minutes in silanized microfuge tubes (Fisher) at room temperature. 
GST alone was used as a protein control for background determination. 30 p.L of 1:2 
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slurry of GSH-agarose in PAB was added, and the reactions were incubated for 30 
minutes with gentle rocking. The supernatant was removed and the beads washed 
one time with 100 jiL PAB before counting. 
Data analysis. ID50 values were calculated by logit-log plot (Bylund & 
Yamamura, 1990), defined by the equation logit = In (P/100-P), where P is the 
percentage of total cpm bound when no competitor is present. Values represent the 
average of two separate determinations. 
Results 
Analysis of substrate binding to the wild-type enzyme. In order to 
detemnine the effects of substrate binding with rat brain PTP-1, we first tested the 
ability of the C215S GST-PTP (denoted as WT) to bind to phosphorylated casein 
peptide (sequence NANEEEpYGIL) The amount of 32p.|abeled casein peptide 
bound to the GST-PTP was PTP-concentration dependent, and was dependent on 
the presence of the PTP (data not shown). We then compared the ability of 
unlabeled phosphocasein and an aryl phosphate, para nitrophenyl phosphate 
(pNPP), to compete with 32p.|abeled phosphocasein for binding. Analysis of binding 
of these substrates was done by comparing their ability to compete for binding with 
trace amounts of the 32p-iabeled casein peptide. Competition binding curves are 
shown in Figure 3.1. This clearly demonstrates that a phosphopeptide substrate is a 
much better competitor than pNPP for displacing the labeled peptide, shown by the 
leftward shift in the competition curve with the phosphocasein peptide. Comparison 
of phosphorylated and unphosphorylated peptide demonstrates that phosphate is 
absolutely required for binding to the PTP, as unphosphorylated casein peptide was 
unable to displace the labeled peptide, even at high concentrations. 
The ID50 values obtained from the binding curves indicate that the 
Figure 3.1. Comparison of peptide and aryl phosphate substrates for ability to bind 
rbPTP-1. Assays were done as described in the Experimental Procedures. Shown 
are the binding curves for pNPP (open squares), peptide NANEEEpYGIL (closed 
diamonds) and peptide NANEEEYGIL (open diamonds). Shown are representative 
curves of two separate experiments. Error bars show SEM of triplicate 
detenninations for each point. 
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phosphorylated casein peptide had a much higher affinity for binding to rbPTP-1 
than pNPP (approximately 4 orders of magnitude higher), shown in Table 3.1. 
Comparison of the ID50 of binding with the Km determined kineticaliy indicates good 
correlation between the two values. Previous kinetic studies with PTP-1 and YOP-
51 suggest that the Km may be a good approximation of binding (Zhang et al., 1994; 
Hippen et al., 1993). Because of the similarity between ID50 and Km, our results are 
consistent with the proposed PTP mechanism. 
Substrate acidic residues enhance peptide binding to rbPTP-1. Peptides 
based on the phosphorylation site of the model substrate lysozyme are also good 
competitors for PTP binding (Figure 3.2). The presence of acidic residues in the 
competitor peptide affects its ability to compete for binding. The WT substrate 
contains acidic residues at the P-5 and the P-1 positions (nomenclature for peptide 
residues is as previously described (Kennelly & Krebs, 1991), where 
phosphotyrosine is at position 0, and N-terminal residues are denoted by P-X, and 
C-terminal residues by P+X). A peptide containing alanine residues at both P-5 and 
P-1 demonstrated the worst competition for binding out of all the RCML peptides 
tested, showing the most rightward binding curve (Figure 3.2A). Changing either 
alanine residue to aspartate shifted each binding curve to the left, demonstrating an 
increased affinity of the P-5 or P-1 acidic peptide for the PTP relative to the peptide 
containing 2 alanines. Similarly, substitution of an acidic residue at P-2 also 
enhanced binding of this peptide to rbPTP-1, compared to the control peptide 
(Figure 3.2B). These results are consistent with the effect of N-terminal substrate 
acidic residues to enhance PTP reactivity (Hippen et al., 1993; Baedke & 
Ingebritsen, 1996). 
Substrate acidics C-terminal to phosphotyrosine also affect binding to the 
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Table 3.1. Comparison of IDso and Km for peptides with rbPTP-1 
Peptide ID50 Km 
pNPPa 8240 4400 
NANEEEpYSIG 0.2 ±0.1 0.2 ±0.1 
NTAGSTApYGILQia 53.6 ±1.6 7.5 ±0.7 
NTDGSTApYGILQI 3.8 ±1.8 2.1 ±0.3 
NTAGSTDpYGILQI 2.0 ±0.1 1.4 ±0.3 
NTDGSTDpYGILQI 0.7 ±0.1 0.8 ±0.1 
Ac-ATAGSTApYGIL-NHgb 7.8 ±0.8 7.4 ±0.5 
Ac-ATAGSDApYGIL-NH2 1.0 ±0.4c 1.7 ±0.0 
Ac-ATAGSTApYGDL-NH2 2.1 ±0.5c 2.8 ±0.1 
^values for the ID50 represent the mean +SEM for two detemiinations. Km 
values are from Hippen, et al, 1993. 
'Values for the ID50 represent the mean+SEM for three determinations. 
Km values are from Baedke & Ingebritsen, 1996. 
cp<0.0025 versus Ac-ATAGSTApYGIL-NHa. Statistics done using the 
Student t test. 
PTP. Substitution of an aspartate at P+2 position in the lysozyme peptide resulted in 
a substrate that exhibited better binding to the enzyme than the control peptide 
(Figure 3.2B), shown by the leftward shift in the binding curve. These results are 
consistent with the effect of a C-tenminal acidic residue to enhance PTP reactivity 
(Baedke & Ingebritsen, 1996). 
Substrate acidic residues demonstrated additivity in their effect on substrate 
binding. The competition binding curve for the WT RCML peptide (containing acidics 
at both P-5 and P-1) is shifted more leftward relative to the curve for either peptide 
containing a single acidic (Figure 3.2A). This result is consistent with the effect of 
multiple substrate acidic residues on rbPTP-1 reactivity (Hippen et al., 1993; Baedke 
Figure 3.2. The effect of the number of and position of substrate acidic residues on 
binding to rbPTPI. Assays were done as described in the Experimental Procedures. 
Error bars show SEM of triplicate determinations for each point. A) Shown are 
binding curves for the following peptides: NTDGSTQpYGILQI (open diamonds), 
NTAGSTDpYGILQI (open triangles), NTDGSTApYGILQI (open circles), and 
NTAGSTApYGILQI (filled diamonds). Shown are representative curves from two 
separate experiments. B) Shown are binding curves for the following peptides: Ac-
ATAGSTApYGIL-NH2 (filled squares), Ac-ATAGSDApYGIL-NHg (open diamonds), 
and Ac-ATAGSTApYGDL-NH2 (open circles). Shown are representative curves 
from three separate experiments. 
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& Ingebrrtsen, 1996). 
The ID50 values for the competition seen in Figure 3.2 confimn the leftward 
shifts observed in the binding curves. For the lysozyme peptides, the peptide 
containing 2 alanine residues exhibited the highest ID50 values (53.6 ^ ), indicating 
that it had the lowest relative affinity for FTP binding of all the peptides in this series. 
Peptides containing single acidic residues showed intermediate ID50 values (2.0 fiM 
and 3.8 p.M for the peptide containing the P-1 or P-5 acidic residue, respectively), 
and the peptide containing both acidic residues exhibited the lowest ID50 (0.7 p.M), 
indicating its relatively high affinity for FTP binding. A significant decrease in the 
ID50 was also observed with the F-2 acidic residue peptide (from 7.8 |iM for the all 
ala peptide to 1.0 p.M with a P-2 asp). Comparison of the ID50 for binding and Km 
showed a similar pattem of decreasing ID50 or Km with increasing number of acidic 
residues in the substrate. This suggests that the Km effect due to acidic residues 
(Hippen et al., 1993; Baedke & Ingebritsen, 1996) is a direct binding effect. 
Comparison of the ID50 and Km of a C-temninal acidic residue substitution 
also demonstrated a pattem of C-terminal residue effects similar to N-temiinal 
acidics. Presence of a P+2 acidic decreased the ID50 from 7.8 jiM (with no acidics) 
to 2.1 nM. This decrease in ID50 is similar to the effect of a C-terminal acidic residue 
on the Km (Baedke & Ingebritsen, 1996), indicating that C-temninal acidics also have 
a direct binding effect. 
Discussion 
Substrate acidic residues have previously been shown to enhance substrate 
reactivity with rbPTP-1, and other FTP's (Hippen et al., 1993; Zhang et al., 1993, 
Hippen, 1993; Ruzzene et al., 1993; Cho et al., 1993). Substrate acidic residues 
exhibit broad positional specificity in enhancing FTP reactivity, and the effect is 
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additive for acidics N-terminal to phosphotyrosine. In addition, the charge of the 
substrate acidic residue is important (Hippen et al., 1993). However, these results 
do not address the mechanism of the substrate acidic residue effect. Here we show 
that the presence of substrate acidic residues directly influences binding of substrate 
to the enzyme. We show that substrate acidic residues also exhibit broad positional 
specificity in the enhancement of substrate binding; N- or C-terminal acidic residues 
each enhance binding. The presence of N-terminal acidics also are additive in their 
effects on binding enhancement. The effects of substrate acidic residues on binding 
correlate well with their effects on substrate reactivity, indicating that substrate acidic 
residues both N- and C-terminal to phosphotyrosine directly affect binding. 
Previous work by Milarski et al. (1993) also examined the effect of substrate 
amino acids surrounding phosphotyrosine on binding to rbPTP-1. Using peptides 
based on phosphorylation site 992 of the EGF receptor (DADEpYLIPQQG), they 
showed that substitution of the P-1 glutamate with alanine actually decreased the 
ID50 of the peptide with rbPTP-1. Also, the range of IDso's they measured are similar 
or slightly lower than what we observed with the lysozyme peptides. The reason for 
these differences is unknown, but may be due to the assay conditions or the 
substrate sequence they used. They did observe no binding of a non-
phosphorylated peptide, consistent with our results. The effect of the other acidic 
residues (at P-2 and P-4) on binding was not tested. 
That substrate acidic residues directly influence substrate binding to rbPTP-1 
suggests that basic residues may be involved in mediating this substrate residue 
effect. Interactions between substrate acidic residues and PTP residues have been 
demonstrated in crystals of PTP-1B complexed with the peptide DADEpYL from the 
EGF receptor (Jia et al., 1995). The structure showed ion-pair interactions of R47 
with the P-1 and P-2 acidic residues of the bound peptide. Surface basic residues 
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have also been shown to influence the substrate reactivity of rbPTP-1 due to 
substrate acidics, as mutation of R47 and/or K120 to alanine significantly decreases 
the reactivity enhancement caused by substrate acidics (Baedke & Ingebritsen, 
1996). These results suggest that substrate acidic residues may interact with PTP 
basic residues to enhance binding. Experiments to test the role of PTP basic 
residues in substrate binding are in progress. 
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CHAPTER 4. GENERAL CONCLUSIONS 
The results described in this dissertation indicate that basic residues in rat 
brain PTP-1 may mediate the reactivity enhancement caused by substrate acidic 
residues. Also, substrate acidic residues can influence substrate binding. These 
results will be discussed in relation to what we already know about substrate-PTP 
interactions in the following sections. 
Effect of substrate acidic residues on wild-type binding 
Substrate acidic residues have previously been shown to enhance substrate 
reactivity with rat brain PTP-1, and other PTP's (Hippen et al., 1993; Zhang et al., 
1993; Hippen, 1993). In this dissertation, 1 show that the presence of substrate 
acidics can also enhance binding of substrates to an inactivated enzyme. This is a 
significant finding because the role of substrate residues in binding has not been 
examined in detail. The data demonstrated that with the WT enzyme, there is broad 
positional specificity for binding (peptides containing single acidics either at P-5, P-2, 
or P-1 were al! able to compete for binding, with IDso's in the low micromolar range), 
and that substrate acidic residues are additive in their effect (i.e. a phosphopeptide 
with two substrate acidics competed for binding better than one with a single acidic). 
These results correlate well with previous kinetic data on the effect of substrate 
acidics on reactivity with rbPTP-1 (Hippen et al., 1993). 
Much of the work on delineating the substrate specificity of PTP's has focused 
on the N-terminal side of the phosphotyrosine of the substrate. However, I show that 
a single acidic residue C-terminal to phosphotyrosine also can increase reactivity 
and enhance binding with rbPTP-1. This is a novel finding, and may be significant 
when considering potential in vivo substrates. A recent study by Hippen (1993) 
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examined the relative reactivity of rbPTP-1, among other PTP's, with a group of 
peptides based on known physiologically important tyrosine-phosphorylated sites. 
While rbPTP-1 was able to dephosphorylate all of the peptides, it showed a marked 
preference for peptides containing acidic residues. In particular, the most reactive 
physiological substrates (PDGFR site 715 and site 394) both contain multiple 
N-temninal acidics and at least one C-tenninai acidic residue. In addition, the least 
reactive physiological substrates (nAChR p and y subunits and PLC-y site783) 
contained fewer N-temninal or no C-terminal acidics and contained N- and/or C-
terminal basic residues. This trend suggests that substrate amino acid composition 
may in part regulate PTP reactivity toward substrates. It would be interesting to 
compare the relative reactivity and/or binding of peptides containing single acidics 
with a peptide containing acidics both N-and C-terminal to the phosphotyrosine to 
see if effect on reactivity or binding of C-terminal acidics correlates with increased 
reactivity of these physiological substrates. 
Effects of PTP basic residue mutations on substrate reactivity 
The effects of substrate acidic residues on rbPTP-1 substrate reactivity and 
binding suggest that substrate amino acids, acidics in particular, may interact with 
specific PTP residues; this results in enhanced reactivity with substrates containing 
acidics. The results of substrate reactivity with the PTP mutants support this 
hypothesis. However, our results indicate that there are no obligatory interactions 
between specific PTP basics and substrate acidic residue positions. That specific 
interactions most likely are not the case is shown most clearly by the R47A and 
K120A mutants. These two basic residues are located spatially on opposite sides of 
the active site on the PTP surface; however, single mutation of either R47 or K120 
had a similar effect on the reactivity enhancement of substrate acidics, decreasing 
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reactivity approximately 75%, and mutation of both residues almost completely 
knocked out the effect of substrate acidics to enhance PTP reactivity. Mutation of 
R24 or K36, which spatially is farther away from the active site on the R47 side, had 
a smaller effect on substrate acidic activity enhancement than either of the other 
mutants. In addition, positional specificity and additivity was not lost when R47 or 
K120 were mutated. If an obligatory ion pair(s) between specific PTP and substrate 
residues was responsible for the activity enhancement due to substrate acidics, then 
one would expect either a loss of additivity, or no enhancement of reactivity with 
substrate acidics at a specific position(s). These results indicate instead that either a 
more general charge effect may be responsible for the increased reactivity due to 
substrate acidics, or that the PTP surface residues show much flexibility, and are 
able to facilitate interactions with substrate acidic residues at a variety of positions. 
These possibilities cannot be distinguished by our data. 
That mutation of R47 and/or K120 to alanine specifically affects substrate 
reactivity enhancement due to acidic residues raises the possibility that these two 
PTP residues may mediate this enhancement effect by affecting binding of 
substrates containing acidic residues. This study is cun-ently in progress. 
The involvement of R47 in substrate reactivity is supported by two 
independent lines of evidence. Co-crystals of PTP-1B complexed with the peptide 
DADEpYL (from the EGF receptor) clearly demonstrate an ion-pair interaction 
between R47 and the P-1 peptide glutamate residue, and a possible ion pair with the 
P-2 aspartate residue. These interactions in the crystal structure correlate well with 
kinetic studies discussed in Chapter 2. Also, PTP-PEST activity is regulated by 
phosphorylation on serine at position 47 relative to the PTP-1 B sequence; this 
phosphorylation results in an increase in Km, while Vm is largely unaffected. (Garton 
& Tonks, 1994). The magnitude of the effect of phosphorylation on PTP-PEST 
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activity is stril<ingly similar to the magnitude of the effect of one substrate acidic 
residue on rbPTP-1 activity (3-4-fold). This suggests that R47 (or analogous 
residues in other PTP's) and substrate acidic residues both mediate substrate-PTP 
interactions. 
The kinetic studies presented in Chapter 2 also indicate that K120 is also 
involved in the ehancement of reactivity due to substrate acidics. K36 and R24 have 
smaller effects on the reactivity enhancement due to substrate acidics. However, 
the effect these residues have on substrate acidic reactivity enhancement was not 
demonstrated in the crystal structure of PTP-1B complexed with peptide (Jia et al., 
1995). This may be because of differences in substrate sequences used in the two 
studies, or because the crystal structure is a static picture of a single conformation, 
while our studies show a more dynamic situation. It will be interesting to compare 
other PTP structures, when available, with the PTP-1 B structure to detemiine the 
role of these residues (or residues in the analogous position) in PTP-substrate 
interactions. 
What is the possible effect of substrate acidics or PTP basic residues in vivo? 
Substrate acidic and PTP basic residues have at most a 4-5-fold effect on substrate 
reactivity in vitro. Also, these residues have a significant effect on Km, and not Vm, 
when PTP kinetic parameters are measured. Garton and Tonks (1994) suggest that 
this could regulate the activity of PTP's toward substrates that exist in vivo at 
concentrations lower than the Km.. Because the effect of mutating a single basic 
residue or replacing substrate acidic residues with alanine is to increase the Km, one 
can speculate that this small effect of a surface basic or substrate acidic residue may 
be sufficient to decrease substrate reactivity in vivo because of a substrate 
concentration effect. This relative decrease in PTP reactivity with potential 
substrates may also work in concert with other strategies used to regulate PTP 
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activity, such as differential subcellular localization of the enzyme, spatial or 
temporally restricted expression, or phosphorylation and/or activation by interaction 
with other proteins, all of which may be used in vivo to control access of PTP's to 
substrates. 
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